	English [member]
Start Date	2021-01-01	2020-01-01
End Date	2021-12-31	2020-12-31
Filing information [line items]
Disclosure of entity information [abstract]
Name of reporting entity	Bupa Arabia for Cooperative Insurance Co.
Company symbol code\| ISIN code	8210 \| SA1210540914
Sector\| Industry group	Financials \| Insurance
Disclosure of document information [abstract]
Whether entity wants to report opening statement of financial position	No
Period covered by financial statements	Annual
Reporting period start date	2021-01-01	2020-01-01
Reporting period end date	2021-12-31	2020-12-31
Description of nature of financial statements	Consolidated
Status of financial statements	Audited
Description of presentation currency	Saudi Arabia, Riyals
Level of rounding used in financial statements	Thousands

	Primary auditor [member]	Second primary auditor [member]
	English [member]	English [member]
Start Date	2021-01-01	2021-01-01
End Date	2021-12-31	2021-12-31
Auditors information [line items]
Details of auditors signing report [abstract]
Name of auditor signing report	Mufaddal A. Ali	Hussain Saleh Asiri
Registration number of auditor	License No. 447	Licence No. 414
Details of audit firm [abstract]
Name of audit firm	PricewaterhouseCoopers	Ernst and Young & Co Public Accountant (Professional Limited Liability Company)
Registration number of audit firm	License No. 25	Registration N0. 45/11/323
Address of audit firm	5th floor, Jameel Square,P.O. Box 16415Jeddah 21464Kingdom of Saudi Arabia	King’s Road Tower – 13th FloorKing Abdulaziz Road (Malek Road)P. O. Box 1994Jeddah 21441Kingdom of Saudi ArabiaHead Office - Riyadh

	English [member]
Start Date	2021-01-01
End Date	2021-12-31
Auditors report [line items]
Disclosures of auditors report [text block]	NA
Contents of auditors report [abstract]
Nature of auditors opinion	Unmodified opinion
Auditors opinion	We have audited the financial statements of Bupa Arabia For Cooperative Insurance Company – a Saudi Joint Stock Company (the “Company”), which comprise the statement of financial position as at 31 December 2021, and the related statement of income, statement of comprehensive income, statement of changes in equity and statement of cash flows for the year then ended, and notes to the financial statements, which include significant accounting policies and other explanatory information.In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as at 31 December 2021, and its financial performance and its cash flows for the year then ended in accordance with International Financial Reporting Standards (“IFRSs”) as endorsed in the Kingdom of Saudi Arabia and other standards and pronouncements issued by the Saudi Organization for Chartered and Professional Accountants (“SOCPA”) (referred to as “IFRS as endorsed in the Kingdom of Saudi Arabia”).
Basis of opinion	We conducted our audit in accordance with International Standards on Auditing that are endorsed in the Kingdom of Saudi Arabia. Our responsibilities under those standards are further described in the Auditors’ responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the professional code of conduct and ethics, endorsed in the Kingdom of Saudi Arabia, that are relevant to our audit of the financial statements, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Key audit matters	Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the financial statements of the current year. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. For the key audit matter below, a description of how our audit addressed the matter is provided in that context:Key audit matterHow our audit addressed the key audit matterValuation of ultimate claim liabilities arising from insurance contractsAs at 31 December 2021, gross outstanding claims and reserves including claims incurred but not reported (IBNR) and premium deficiency reserve amounted to Saudi Riyals 2.1 billion as reported in Note 13.2 to the financial statements. The estimation of insurance contract liabilities involves a significant degree of judgement. The liabilities are based on the best-estimate of the ultimate cost of all claims incurred but not settled at the reporting date, whether reported or not, together with the related claims handling costs. Accordingly, this complexity arises from calculating the actuarial best estimate and the margin over best estimate using historical data which is sensitive to external inputs, such as claims cost inflation and medical trends, as well as the actuarial methodology that is applied and the assumptions on current and future events. The Company calculates its own estimate of the provision using standardised reserving methodology for comparing against the provision calculated by the independent actuary, and considers the impact of any significant differences. Due to the inherent estimation uncertainty and subjectivity, including additional uncertainties due to COVID-19 pandemic, involved in the assessment of valuation of the ultimate claim liabilities arising from insurance contracts, we have considered this as a key audit matter. We performed the following proceduresUnderstood, evaluated and tested key controls around the claims handling and provision setting processes.Evaluated the competence, capabilities and objectivity of the management's actuarial expert based on their professional qualifications and experience and assessed their independence.Performed substantive tests on the amounts recorded for a sample of claims notified and paid; including comparing the outstanding claims amount to appropriate source documentation to evaluate the valuation of outstanding claim reserves.Obtained sufficient audit evidence to assess the integrity of data used as inputs into the actuarial valuations, and tested on a sample basis, the accuracy of the underlying claims data utilised by management's actuarial expert in estimating the IBNR by comparing it to the accounting and other records.Challenged management's methods and assumptions, using the expertise of our internal actuaries to understand and evaluate the Company's actuarial practices and provisions established. We gained comfort over the actuarial report issued by management's expert, by performing the following:Please refer to notes 3(xxi) for the accounting policy adopted by the Company and note 2d(i) for the significant accounting judgements, estimates and assumptions involved in the initial recognition and subsequent measurement of claims. Also, refer to note 13 for the movement in outstanding claims.i.Evaluated whether the Company's actuarial methodologies were consistent with generally accepted actuarial practices and with prior years. We sought sufficient justification for any significant differences;ii.Assessed key actuarial assumptions including claims ratios and expected frequency and severity of claims. We challenged these assumptions by comparing them with our expectations based on the Company's historical experience, current trends and our own industry knowledge; andiii.Reviewed the appropriateness of the calculation methods and approach along with the assumptions used and sensitivity analysis performed.Assessed the adequacy and appropriateness of the related disclosures in the financial statements.
Responsibilities of management and those charged with governance for financial statements	Management is responsible for the other information. Other information consists of the information included in the Company’s 2021 Annual Report other than the financial statements and our auditors’ report thereon. The Company’s 2021 Annual Report is expected to be made available to us after the date of this auditors’ report. Our opinion on the financial statements does not cover the other information and we will not express any form of assurance conclusion thereon.In connection with our audit of the financial statements, our responsibility is to read the other information identified above when it becomes available and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. When we read the other information, if we conclude that there is a material misstatement therein, we are required to communicate the matter to those charged with governance.Management is responsible for the preparation and fair presentation of the financial statements in accordance with IFRS as endorsed in the Kingdom of Saudi Arabia, the applicable requirements of the Regulations for Companies, the Company’s By-laws and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.In preparing the financial statements, management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.Those charged with governance i.e. the Board of Directors of the Company is responsible for overseeing the Company’s financial reporting process.
Auditors responsibilities for audit of financial statements	Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with International Standards on Auditing as endorsed in the Kingdom of Saudi Arabia will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.As part of an audit in accordance with International Standards on Auditing as endorsed in the Kingdom of Saudi Arabia, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control.Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Company to cease to continue as a going concern.Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements of the current year and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.
Date of signing audit report by auditor	2022-03-02

Start Date	2021-01-01	2020-01-01	Note No.
End Date	2021-12-31	2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Insurance/ takaful operations assets [abstract]
Deferred policy acquisition costs	201,042	68,214	14
Reinsurers/ retakaful share of unearned premiums/ contributions	27,935	20,108	13.1
Prepayments and other assets, insurance/ takaful operations assets	99,998	71,167	8
Premiums/ insurance receivables/takaful contributions receivable, net	1,761,300	1,320,043	6
Reinsurers/ retakaful share of outstanding claims/ benefits, net	15,036	7,936	13.2
Time (Murabaha) deposits, insurance/ takaful operations assets	2,007,922	1,645,292	9
Investments held at fair value through statement of income, insurance/ takaful operations assets	2,599,429	3,568,181	7
Cash and cash equivalents, insurance/ takaful operations assets	930,691	195,232	5
Total insurance/ takaful operations assets	7,643,353	6,896,173
Shareholders assets [abstract]
Property and equipment, net, shareholders assets	182,387	204,019	10
Goodwill	98,000	98,000	4
Intangible assets	67,277	61,958	11
Statutory deposit	120,000	120,000	12
Prepayments and other assets, shareholders assets	13,256	13,919	8
Investments held at fair value through statement of income, shareholders assets	3,104,344	2,461,265	7
Time (Murabaha) deposits, shareholders assets	1,085,798	1,151,255	9
Cash and cash equivalents, shareholders assets	30,067	438,019	5
Other assets, shareholders assets	54,620	51,747	26b - 12
Total shareholders assets	4,755,749	4,600,182
Total assets	12,399,102	11,496,355
Liabilities and equity [abstract]
Insurance/ takaful operations liabilities and surplus (deficit) [abstract]
Insurance/ takaful operations liabilities [abstract]
Gross unearned premiums/ contributions	4,709,555	4,023,331	13.1
Surplus distribution payable	190,060	200,391	20
Reinsurers/ retakaful balance payable	25,397	4,873	25
Gross outstanding claims/ benefits including IBNR payable	2,111,455	2,109,319	13.2
Accrued expenses payable, insurance/ takaful operations liabilities	597,911	534,201	18
Total insurance/ takaful operations liabilities	7,634,378	6,872,115
Total insurance/ takaful operations liabilities and surplus (deficit)	7,634,378	6,872,115
Shareholders liabilities and equity [abstract]
Shareholders liabilities [abstract]
Zakat payable	202,820	285,448	26.c
Income tax payable	33,790	31,751	26.c
Due to related parties, shareholders liabilities	33,723	108,521	24
Accrued expenses payable, shareholders liabilities	132,196	141,849	18
Other liabilities, shareholders liabilities	167,171	153,818	21-12
Total shareholders liabilities	569,700	721,387
Shareholders equity [abstract]
Equity attributable to owners of parent [abstract]
Share capital	1,200,000	1,200,000	27
Statutory reserve	992,210	867,096	28
Fair value reserve on investments, shareholders equity	236,633	174,848
Retained earnings (accumulated losses)	1,790,700	1,684,003
Share based payments reserve	-9,856	-15,979	29
Other equity interest	-14,663	-7,115
Total equity attributable to owners of parent	4,195,024	3,902,853
Total equity attributable to equity holders of company	4,195,024	3,902,853
Total shareholders liabilities and equity	4,764,724	4,624,240
Total insurance/ takaful operations liabilities, surplus (deficit) and shareholders liabilities and equity	12,399,102	11,496,355

Start Date	2021-01-01	2020-01-01	Note No.
End Date	2021-12-31	2020-12-31
Statement of insurance/ takaful operations [abstract]
Statement of insurance/ takaful operations and accumulated surplus (deficit) [abstract]
Income from insurance/ takaful operations [abstract]
Net premiums/ contributions earned [abstract]
Net premiums/ contributions written [abstract]
Gross premiums/ contributions written	11,382,194	10,447,353	13.1
Reinsurance/ retakaful premiums ceded	86,082	65,242
Net premiums/ contributions written	11,296,112	10,382,111
Changes in unearned premiums/ contributions	678,397	-352,371
Net premiums/ contributions earned	10,617,715	10,734,482	13.1
Investment income from insurance/ takaful operations, net	84,843	121,788	33
Fees and other income from insurance/ takaful operations	-4,985	-3,762
Total income from insurance/ takaful operations	10,697,573	10,852,508
Cost and expenses [abstract]
Net claims/ benefits incurred [abstract]
Net claims/ benefits paid [abstract]
Gross claims/ benefits paid	9,073,926	8,262,050
Reinsurance/ retakaful share of gross claims/ benefits paid	22,393	20,987
Net claims/ benefits paid	9,051,533	8,241,063
Changes in outstanding claims/ benefits including IBNR	2,136	481,611	13.2
Changes in reinsurance/ retakaful share of outstanding claims/ benefits	-7,100	-2,746
Net claims/ benefits incurred	9,046,569	8,719,928
Policy acquisition costs	343,427	630,734	14
General and administrative expenses, insurance/ takaful operations	586,004	565,199	31
Selling and marketing expenses, insurance/ takaful operations	115,646	106,467	32
Other cost and expenses	22,458	28,770	6
Total cost and expenses	10,114,104	10,051,098
Surplus (deficit) for period from insurance/ takaful operations	583,469	801,410
Shareholders appropriation from insurance/ takaful operations surplus (deficit)	525,122	721,269	20
Net result for period from insurance/ takaful operations after shareholders appropriation	58,347	80,141	20
Policyholders share of accumulated surplus, at start of period	0	0
Policyholders share of accumulated surplus, at end of period	58,347	80,141

Start Date	2021-01-01	2020-01-01	Note No.
End Date	2021-12-31	2020-12-31
Statement of shareholders operations [abstract]
Profit (loss) [abstract]
Income (loss) from continuing operations [abstract]
Shareholders appropriation of surplus (deficit) transferred from insurance/ takaful operations	525,122	721,269	20
Revenue [abstract]
Investment income	175,594	91,507	33
Other income	42,575	31,243
Total revenue	218,169	122,750
Expenses [abstract]
General and administrative expenses, shareholders operations	12,590	20,350	31
Total expenses	12,590	20,350
Income (loss) from continuing operations before zakat and income tax	730,701	823,669
Zakat expenses on continuing operations for period	41,136	64,297	26.a
Income tax on continuing operations for period	63,995	63,244	26.b
Profit (loss) from continuing operations	625,570	696,128
Income (loss) from discontinued operations [abstract]
Income (loss) from discontinued operations	0	0
Gain (loss) on disposal of discontinued operations	0	0
Other incidental incomes (expenses) resulting from discontinued operations	0	0
Profit (loss) from discontinued operations before zakat and income tax	0	0
Zakat expenses on discontinued operations for period	0	0
Income tax on discontinued operations for period	0	0
Profit (loss) from discontinued operations	0	0
Profit (loss) for the period	625,570	696,128
Profit (loss), attributable to [abstract]
Profit (loss), attributable to saudi shareholders of company	625,570	696,128
Profit (loss), attributable to non-saudi shareholders of company	0	0
Profit (loss), attributable to non-controlling interests	0	0
Earnings per share [abstract]
Basic earnings (loss) per share [abstract]
Basic earnings (loss) per share from continuing operations	5.2324	5.83	34
Basic earnings (loss) per share from discontinued operations	0	0
Total basic earnings (loss) per share	5.2324	5.83
Diluted earnings (loss) per share [abstract]
Diluted earnings (loss) per share from continuing operations	0	0
Diluted earnings (loss) per share from discontinued operations	0	0
Total diluted earnings (loss) per share	0	0
Weighted average number of equity shares outstanding	119558	119421
Share closing price at the last trading day of financial year (in numbers)	131.4	122.2

Start Date	2021-01-01	2020-01-01
End Date	2021-12-31	2020-12-31
Statement of other comprehensive income, before tax [abstract]
Net result for period from insurance/ takaful operations after shareholders appropriation	58,347	80,141
Other comprehensive income [abstract]
Components of other comprehensive income that will be reclassified to profit or loss [abstract]
Other comprehensive gains (losses) that will be reclassified to profit or loss	-15,083	11,554
Total other comprehensive income (loss), that will be reclassified to profit or loss	-15,083	11,554
Total other comprehensive income (loss)	-15,083	11,554
Total comprehensive income (loss) for period	43,264	91,695

Start Date	2021-01-01	2020-01-01
End Date	2021-12-31	2020-12-31
Statement of other comprehensive income, before tax [abstract]
Statement of comprehensive income [abstract]
Profit (loss) for the period	625,570	696,128
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss [abstract]
Remeasurement gains (losses) on defined benefit plans	7,535	-20,700
Total other comprehensive income that will not be reclassified to profit or loss	7,535	-20,700
Components of other comprehensive income that will be reclassified to profit or loss [abstract]
Other comprehensive gains (losses) that will be reclassified to profit or loss	61,785	156,813
Total other comprehensive income (loss), that will be reclassified to profit or loss	61,785	156,813
Total other comprehensive income (loss)	69,320	136,113
Total comprehensive income (loss) for period	694,890	832,241
Total comprehensive income (loss) attributable to [abstract]
Total comprehensive income (loss), attributable to saudi shareholders of company	694,890	832,241
Total comprehensive income (loss), attributable to non-saudi shareholders of company	0	0
Total comprehensive income (loss), attributable to non-controlling interests	0	0

Start Date	2021-01-01	2020-01-01	Note No.
End Date	2021-12-31	2020-12-31
Statement of cash flows, indirect method [abstract]
Statement of cash flows, insurance/ takaful operations [abstract]
Cash flows from (used in) operating activities, insurance/ takaful operations [abstract]
Net result for period from insurance/ takaful operations after shareholders appropriation	58,347	80,141	20
Adjustments to reconcile net income to net cash from insurance/ takaful operations after shareholders appropriation
Adjustments for depreciation, insurance/ takaful operations cash flow	31,155	31,507
Adjustments for unrealised (gains) losses on investments held as fair value through statement of income	0	-1,058
Adjustments for allowance for doubtful receivables	22,458	28,770
Adjustments for (gains) losses on disposal of investments, insurance/ takaful operations cash flow	-31,182	-79,901
Other adjustments to reconcile net income to net cash from insurance/ takaful operating activities	14,446	15,731
Total adjustments to reconcile net income to net cash from insurance/ takaful operations after shareholders appropriation	36,877	-4,951
Changes in operating assets and liabilities [abstract]
Adjustments for decrease (increase) in premium receivables, net	-463,715	340,564
Adjustments for decrease (increase) in prepayments and other assets	-28,831	92,167
Adjustments for increase (decrease) in outstanding claims including IBNR	2,136	481,611
Adjustments for increase (decrease) in reinsurers/ retakaful balance payable	20,524	-49,540
Adjustments for increase (decrease) in accrued expenses and other liabilities	63,710	181,403
Adjustments for decrease (increase) in reinsurers/ retakaful share of outstanding claims, net	-7,100	-2,746
Adjustments for decrease (increase) in deferred policy acquisition costs	-132,828	65,808
Adjustments for increase (decrease) in due to shareholders operations	-48,133	-47,239
Adjustments for movement in gross unearned premiums/ contributions	686,224	-352,888
Adjustments for reinsurance/ retakaful share of unearned premiums/ contributions	-7,827	517
Adjustments for other changes in operating assets and liabilities, insurance/ takaful operations cash flow	-68,678	-48,204
Total changes in operating assets and liabilities	15,482	661,453
Net cash flows from (used in) insurance/ takaful operations	110,706	736,643
Other inflows (outflows) of cash classified as operating activities, insurance/ takaful operations cash flow	0	0
Net cash flows from (used in) operating activities, insurance/ takaful operations	110,706	736,643
Cash flows from (used in) investing activities, insurance/ takaful operations [abstract]
Time (Murabaha) deposits, insurance/ takaful operations cash flow	-331,448	1,841,664
Proceeds from sales of investments held as fair value through statement of income, insurance/ takaful operations cash flow	9,088,961	6,935,704
Purchase of investments, insurance/ takaful operations cash flow	8,132,760	9,765,721
Net cash flows from (used in) investing activities, insurance/ takaful operations	624,753	-988,353
Cash flows from (used in) financing activities, insurance/ takaful operations [abstract]
Adjustments for decrease (increase) in due from shareholders operations	0	0
Adjustments for increase (decrease) in due to shareholders operations	0	0
Due to related party, insurance/ takaful operations cash flow	0	0
Surplus paid to policyholders	0	0
Payments to acquire or redeem treasury shares	0	0
Other inflows (outflows) of cash classified as financing activities, insurance/ takaful operations cash flow	0	0
Net cash flows from (used in) financing activities, insurance/ takaful operations	0	0
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	735,459	-251,710
Net increase (decrease) in cash and cash equivalents	735,459	-251,710
Cash and cash equivalents at beginning of period	195,232	446,942
Cash and cash equivalents at end of period	930,691	195,232
Non-cash supplemental information, insurance/ takaful operations [abstract]
Operational cash flows from interest and dividends [abstract]
Interest paid, insurance/ takaful operations	0	0
Interest received, insurance/ takaful operations	0	0
Dividend received, insurance/ takaful operations	0	0

Start Date	2021-01-01	2020-01-01	Note No.
End Date	2021-12-31	2020-12-31
Statement of cash flows, indirect method [abstract]
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Net profit (loss) for period [abstract]
Income (loss) from continuing operations before zakat and income tax	730,701	823,669
Profit (loss) from discontinued operations before zakat and income tax	0	0
Net profit (loss) for period (before zakat expenses and income tax)	730,701	823,669
Adjustments to reconcile profit (loss) [abstract]
Adjustments for unrealised loss (gain) on investments held as fair value through statement of income, shareholders cash flow	-2,643	182
Adjustments for realised loss (gain) on investments held as fair value through statement of income, shareholders cash flow	-27,175	-40,277
Other adjustments for non-cash items	53,715	48,572
Total adjustments to reconcile profit (loss)	23,897	8,477
Changes in operating assets and liabilities [abstract]
Adjustments for increase (decrease) in accrued expenses and other liabilities, shareholders cash flow	614	689
Adjustments for increase (decrease) in amount due to related parties, shareholders cash flow	-60,557	27,800	24
Adjustments for decrease (increase) in due from insurance/ takaful operations	48,133	47,239
Adjustments for decrease (increase) in prepayments and other assets, shareholders assets	663	9,056
Adjustments for miscellaneous other working capital changes	2,521	0
Total changes in operating assets and liabilities	-8,626	84,784
Net cash flows from (used in) operations	745,972	916,930
Zakat expenses	0	0
Income taxes refund (paid)	0	0
Other inflows (outflows) of cash	-195,200	-97,099
Net cash flows from (used in) operating activities	550,772	819,831
Cash flows from (used in) investing activities [abstract]
Purchase of shares under long-term incentive plan (LTIP)	0	0
Purchase of investments	7,033,358	3,983,139
Proceeds from sales of investments	6,452,175	2,793,785
Proceeds form Murabaha/ time deposits matured during the period	466,960	936,277
Purchase of term deposits investments	374,328	300,000
Purchase of property and equipment	9,115	11,840
Proceeds from disposal of property and equipment	0	0
Other inflows (outflows) of cash	-19,765	-21,444
Net cash flows from (used in) investing activities	-517,431	-586,361
Cash flows from (used in) financing activities [abstract]
Payments of finance lease liabilities	19,030	14,218
Dividends paid	408,000	0
Other inflows (outflows) of cash	-14,263	0
Net cash flows from (used in) financing activities	-441,293	-14,218
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	-407,952	219,252
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	-407,952	219,252
Cash and cash equivalents at beginning of period	438,019	218,767
Cash and cash equivalents at end of period	30,067	438,019

[400100] Notes forming part of accounts

	English [member]	Note No.
Start Date	2021-01-01
End Date	2021-12-31
Notes forming part of accounts [line items]
Disclosure of notes and other explanatory information [text block]
Disclosure of general information about reporting entity [abstract]
Disclosure of general information about reporting entity [text block]	Bupa Arabia for Cooperative Insurance Company (the “Company”) is a Saudi Joint Stock Company incorporated in the Kingdom of Saudi Arabia as per the Ministry of Commerce’s resolution number 138/K dated 24 Rabi Thani 1429H (corresponding to 1 May 2008). The Commercial Registration number of the Company is 4030178881 dated 5 Jumad Awwal 1429H (corresponding to 11 May 2008). The Registered Office of the Company is situated at:Al-Khalediyah District, Prince Saud Al Faisal Street,Front of Saudi Airlines Cargo Building,P.O. Box 23807, Jeddah 21436, Kingdom of Saudi Arabia.The Company is licensed to conduct insurance business in the Kingdom of Saudi Arabia under cooperative principles in accordance with Royal Decree No. M/74 dated 29 Shabaan 1428H (corresponding to 11 September 2007) pursuant to the Council of Ministers’ Resolution No 279 dated 28 Shabaan 1428H (corresponding to 10 September 2007).The objective of the Company is to transact cooperative insurance operations and related activities in the Kingdom of Saudi Arabia in accordance with its articles of association, and applicable regulations in the Kingdom of Saudi Arabia. The Company underwrites medical insurance only. The Board of Directors approves the distribution of the surplus from insurance operations in accordance with the Implementing Regulations issued by the Saudi Central Bank (“SAMA”), whereby the shareholders of the Company are to receive 90% of the annual surplus from insurance operations and the policyholders are to receive the remaining 10%. Any deficit arising on insurance operations is transferred to the shareholders’ operations in full.	1
Disclosure of basis of preparation of financial statements [text block]	The financial statements of the Company have been prepared in accordance with International Financial Reporting Standards (IFRSs) as endorsed in the Kingdom of Saudi Arabia, and other standards and pronouncement issued by Saudi Organisation for Chartered and Professional Accountants (“SOCPA”) (referred to as “IFRS as endorsed in KSA”).	2.A
Disclosure of accounting framework used in preparation of financial statements [text block]	As required by the Saudi Arabian Insurance Regulations (The Implementation Regulations), the Company maintains separate books of accounts for “Insurance Operations” and “Shareholders’ Operations”. Accordingly, assets, liabilities, revenues and expenses attributable to either operation are recorded in the respective accounts. Note 36 to these financial statements provides the statement of financial position, statements of income, comprehensive income and cash flows of the insurance operations and shareholders operations, separately.During 2018, SAMA issued illustrative financial statements for the insurance sector in the Kingdom of Saudi Arabia. In preparing the Company level financial statements in compliance with IFRS as endorsed in the Kingdom of Saudi Arabia, the balances and transactions of insurance operations are combined with those of shareholders’ operations. Inter-operation balances and transactions, if any, are eliminated in full. The accounting policies adopted for the insurance and shareholders’ operations are uniform for like transactions and events in similar circumstances.	2.A
Disclosure of new standards and amendments in standards [text block]	The significant accounting policies applied in the preparation of these financial statements are summarised below. These policies have been consistently applied to each of the years presented except new IFRS standards, IFRIC interpretations and amendments thereof, adopted by the Company as explained below:a)New IFRS Standards, IFRIC interpretations and amendments thereof, adopted by the Company: The following new standards, amendments and revisions to existing standards, which were issued by the International Accounting Standards Board (IASB), have been effective from 1 January 2021 and accordingly adopted by the Company. The Company has assessed that the amendments have no significant impact on the Company’s financial statements, as applicable:Standard / AmendmentsDescriptionEffective dateAmendment to IFRS 16, ‘Leases’ – COVID-19 related rent concessionsAs a result of the coronavirus (COVID-19) pandemic, rent concessions have been granted to lessees. Such concessions might take a variety of forms, including payment holidays and deferral of lease payments. On 28 May 2020, the IASB published an amendment to IFRS 16 that provides an optional practical expedient for lessees from assessing whether a rent concession related to COVID-19 is a lease modification. Lessees can elect to account for such rent concessions in the same way as they would if they were not lease modifications. In many cases, this will result in accounting for the concession as variable lease payments in the period(s) in which the event or condition that triggers the reduced payment occurs.Annual periods beginning on or after 1 June 2020	3.A
Disclosure of issued IFRS not yet adopted [text block]	b)Standards issued but not yet effective: Standards issued but not yet effective up to the date of issuance of the Company’s annual financial statements are listed below. The Company intends to adopt these standards when they become effective.Standard, interpretation, amendmentsDescriptionEffective dateAmendment to IFRS 16, ‘Leases’ – COVID-19 related rent concessions Extension of the practical expedientAs a result of the coronavirus (COVID-19) pandemic, rent concessions have been granted to lessees. In May 2020, the IASB published an amendment to IFRS 16 that provided an optional practical expedient for lessees from assessing whether a rent concession related to COVID-19 is a lease modification. On 31 March 2021, the IASB published an additional amendment to extend the date of the practical expedient from 30 June 2021 to 30 June 2022. Lessees can select to account for such rent concessions in the same way as they would if they were not lease modifications. In many cases, this will result in accounting for the concession as variable lease payments in the period(s) in which the event or condition that triggers the reduced payment occurs.Annual periods beginning on or after 1 April 2021.A number of narrow-scope amendments to IFRS 3, IAS 16, IAS 37 and some annual improvements on IFRS 1, IFRS 9, IAS 41 and IFRS 16.Amendments to IFRS 3, ‘Business combinations’ update a reference in IFRS 3 to the Conceptual Framework for Financial Reporting without changing the accounting requirements for business combinations.Amendments to IAS 16, ‘Property, plant and equipment’ prohibit a company from deducting from the cost of property, plant and equipment amounts received from selling items produced while the company is preparing the asset for its intended use. Instead, a company will recognise such sales proceeds and related cost in statement of income.Amendments to IAS 37, ‘Provisions, contingent liabilities and contingent assets’ specify which costs a company includes when assessing whether a contract will be loss-making.Annual improvements make minor amendments to IFRS 1, ‘First-time Adoption of IFRS’, IFRS 9, ‘Financial instruments’, IAS 41, ‘Agriculture’ and the Illustrative Examples accompanying IFRS 16, ‘Leases’.Annual periods beginning on or after 1 January 2022.Standard, interpretation, amendmentsDescriptionEffective dateNarrow scope amendments to IAS 1, Practice statement 2 and IAS 8The amendments aim to improve accounting policy disclosures and to help users of the financial statements to distinguish between changes in accounting estimates and changes in accounting policies.Annual periods beginning on or after 1 January 2023.Amendment to IAS 12- deferred tax related to assets and liabilities arising from a single transactionThese amendments require companies to recognise deferred tax on transactions that, on initial recognition give rise to equal amounts of taxable and deductible temporary differences.Annual periods beginning on or after 1 January 2023.IFRS 17Insurance ContractsSee note belowIFRS 9Financial InstrumentsSee note belowIFRS 17 – Insurance ContractsOverviewThis standard which was published on May 18, 2017 it establishes the principles for the recognition, measurement, presentation and disclosure of insurance contracts and supersedes IFRS 4 – Insurance contracts.The new standard applies to insurance contracts issued, to all reinsurance contracts and to investment contracts with discretionary participating features provided the entity also issues insurance contracts. It requires to separate the following components from insurance contracts:i)embedded derivatives, if they meet certain specified criteria;ii)distinct investment components; andiii)any promise to transfer distinct goods or non-insurance services.These components should be accounted for separately in accordance with the related standards (IFRS 9 and IFRS 15).MeasurementIn contrast to the requirements in IFRS 4, which permitted insurers to continue to use the accounting policies for measurement purposes that existed prior to January 2005, IFRS 17 provides the following different measurement models:The General model is based on the following “building blocks”:a)The Fulfilment Cash flows (FCF), which consists of:probability-weighted estimates of future cash flows;an adjustment to reflect the time value of money (i.e. discounting) and the financial risks associated with those future cash flows; anda risk adjustment for non-financial risk.b)the Contractual Service Margin (CSM). The CSM represents the unearned profit for a group of insurance contracts and will be recognized as the entity provides services in the future. The CSM cannot be negative at inception; any net negative amount of the fulfilment cash flows at inception will be recorded in profit or loss immediately. At the end of each subsequent reporting period the carrying amount of a group of insurance contracts is remeasured to be the sum of:- - the liability for remaining coverage, which comprises the FCF related to future services and the CSM of the group at that date; and- the liability for incurred claims, which is measured as the FCF related to past services allocated to the group at that date.The CSM is adjusted subsequently for changes in cash flows related to future services but the CSM cannot be negative, so changes in future cash flows that are greater than the remaining CSM are recognized in statement of income. Interest is also accreted on the CSM at rates locked in at initial recognition of a contract (i.e. discount rate used at inception to determine the present value of the estimated cash flows). Moreover, the CSM will be released into statement of income based on coverage units, reflecting the quantity of the benefits provided and the expected coverage duration of the remaining contracts in the group.The Variable Fee Approach (VFA) is a mandatory model for measuring contracts with direct participation features (also referred to as ‘direct participating contracts’). This assessment of whether the contract meets these criteria is made at inception of the contract and not reassessed subsequently. For these contracts, the CSM is also adjusted for in addition to adjustment under general model.1)changes in the entity’s share of the fair value of underlying items; and2)changes in the effect of the time value of money and financial risks not relating to the underlying items.In addition, a simplified Premium Allocation Approach (PAA) is permitted for the measurement of the liability for the remaining coverage if it provides a measurement that is not materially different from the general model or if the coverage period for each contract in the group is one year or less. With the PAA, the liability for remaining coverage corresponds to premiums received at initial recognition less insurance acquisition cash flows, unless the Company chooses to recognise the payments as an expense. The general model remains applicable for the measurement of incurred claims. However, the entity is not required to adjust future cash flows for the time value of money and the effect of financial risk if those cash flows are expected to be paid/received in one year or less from the date the claims are incurred.Effective dateThe effective date of IFRS 17 and the deferral of the IFRS 9 temporary exemption in IFRS 4, is currently January 1, 2023. Earlier application is permitted if both IFRS 15 – Revenue from Contracts with Customers and IFRS 9 – Financial Instruments have also been applied. The Company intend to apply the standard on its effective date.TransitionRetrospective application is required. However, if full retrospective application for a group of insurance contracts is impracticable, then the entity is required to apply either a modified retrospective approach or a fair value approach.Presentation and DisclosuresThe Company expects that the new standard will result in a change in accounting policies for insurance contracts together with amendments to presentation and disclosures.ImpactThe Company is currently assessing the impact of the application and implementation of IFRS 17. As of the date of the publication of these financial statements, the Company expects the implementation of IFRS 17 to have impact on the following areas:Impact Area Summary of Impact Financial Impact The financial impact of applying IFRS 17 compared to IFRS 4 was not significant based on the assessment conducted in 2020.Data Impact Management is assessing data storage and infrastructure considering systems interfaces and data integrity. However, management believes that the data impact is not likely to be significant. IT Systems Management is assessing the current IT systems and considering the migration to a new system in phases by utilizing the current system capabilities before the migration is carried out ensuring IFRS17 disclosure and reconciliation requirements are met. Process Impact The Company will need to establish new processes to ensure that required line items and additional breakdowns are fed into downstream systems to create the required presentations and disclosures. Impact on RI Arrangements The Company’s reinsurance arrangements are not material (less than 1% of GWP is reinsured). New/enhanced systems would be flexible to account for any changes in the Company’s reinsurance strategy. Impact on Policies & Control Frameworks The Company needs to update the actuarial and accounting policies and develop guidance papers; From governance perspective, management needs to make sure all IFRS17 key decisions and results are appropriately reviewed and signed off by the auditors, appointed actuary, audit committee as well as the board of directors and internal control functions. IFRS 9 – Financial Instruments OverviewThis standard was published on 24 July 2014 and has replaced IAS 39. The new standard addresses the following items related to financial instruments:Classification and measurementIFRS 9 uses a single approach to determine whether a financial asset is measured at amortized cost, fair value through other comprehensive income or fair value through statement of income. A financial asset is measured at amortized cost if both:i)the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows and;ii)the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding (“SPPI”).The financial asset is measured at fair value through other comprehensive income and realized gains or losses would be classified through the statement of income upon sale, if both conditions are met:1)the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows and for sale and;2)the contractual terms of cash flows are SPPI.Assets not meeting either of these categories are measured at fair value through statement of income. Additionally, at initial recognition, an entity can use the option to designate a financial asset at fair value through statement of income if doing so eliminates or significantly reduces an accounting mismatch.For equity instruments that are not held for trading, an entity can also make an irrevocable election to present in other comprehensive income subsequent changes in the fair value of the instruments (including realized gains and losses), dividends being recognized in statement of income.Additionally, for financial liabilities that are designated as at fair value through statement of income, the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is recognized in other comprehensive income, unless the recognition of the effects of changes in the liability’s credit risk in other comprehensive income would create or enlarge an accounting mismatch in statement of income.ImpairmentThe impairment model under IFRS 9 reflects expected credit losses, as opposed to incurred credit losses under IAS 39. Under the IFRS 9 approach, it is no longer necessary for a credit event to have occurred before credit losses are recognized. Instead, an entity always accounts for expected credit losses and changes in those expected credit losses. The amount of expected credit losses is updated at each reporting date to reflect changes in credit risk since initial recognition.Hedge accountingIFRS 9 introduces new requirements for hedge accounting that align hedge accounting more closely with Risk Management. The requirements establish a more principles-based approach to the general hedge accounting model. The amendments apply to all hedge accounting with the exception of portfolio fair value hedges of interest rate risk (commonly referred to as “fair value macro hedges”). For these, an entity may continue to apply the hedge accounting requirements currently in IAS 39. This exception was granted largely because the IASB is addressing macro hedge accounting as a separate project.Effective dateThe published effective date of IFRS 9 was 1 January 2018. However, amendments to IFRS 4 – Insurance Contracts: Applying IFRS 9 – Financial Instruments with IFRS 4 – Insurance Contracts, published on 12 September 2016, changes the existing IFRS 4 to allow entities issuing insurance contracts within the scope of IFRS 4 to mitigate certain effects of applying IFRS 9 before the IASB’s new insurance contract standard (IFRS 17 – Insurance Contracts) becomes effective. The amendments introduce two alternative options:1)apply a temporary exemption from implementing IFRS 9 until the earlier of:أ‌)the effective date of a new insurance contract standard; orب‌)annual reporting periods beginning on or after January 1, 2023. Additional disclosures related to financial assets are required during the deferral period. This option is only available to entities whose activities are predominately connected with insurance and have not applied IFRS 9 previously; or;2)adopt IFRS 9 but, for designated financial assets, remove from statement of income the effects of some of the accounting mismatches that may occur before the new insurance contract standard is implemented. During the interim period, additional disclosures are required.The Company performed a detailed assessment beginning 1 January 2017: (1) The carrying amount of the Company’s liabilities arising from contracts within the scope of IFRS 4 (including deposit components or embedded derivatives unbundled from insurance contracts) were compared to the total carrying amount of all its liabilities; and (2) the total carrying amount of the company’s liabilities connected with insurance were compared to the total carrying amount of all its liabilities. Based on these assessments the Company determined that it is eligible for the temporary exemption. Consequently, the Company has decided to defer the implementation of IFRS 9 until the effective date of the new insurance contracts standard. Disclosures related to financial assets required during the deferral period are included in the Company’s financial statements.Impact assessment As at December 31, 2021, the Company has total financial assets and insurance related assets amounting to SR 9,298 million and SR 2,724 million, respectively. Financial assets mainly represent: Cash and cash equivalents, Held to maturity investments, Term deposits and designated sukuks amounting to SR 3,925 million (2020: SR 2,854 million). FVSI investments amounting to SR 3,258 million (2020: SR 3,695 million). Other financial assets, including available for sale investments amounting to SR 2,115 million (2020: SR 2,203 million).The Company is still finalizing its assessment to measure the impact of applying and implementing IFRS 9. The Company, however, does not expect IFRS 9 to have a material impact on the classification and measurement of financial assets.	3.B
Disclosure of critical accounting judgements, estimates and assumptions, general [text block]	The preparation of the Company’s financial statements requires management to make judgments, estimates and assumptions that affect the reported amount of revenue, expenses, assets and liabilities, and the accompanying disclosures. Uncertainty about these assumptions and estimates could result in outcomes that require material adjustment to the carrying amount of assets or liabilities affected in future years. Estimates and judgments are continually evaluated and based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The following are the accounting judgments and estimates that are critical in the preparation of these financial statements:i)The ultimate liability arising from claims made under insurance contractsJudgment by management is required in the estimation of amounts due to medical providers and third parties arising from claims made under insurance contracts. Such estimates are necessary based on assumptions derived from several factors involving varying degrees of judgment and uncertainty as well as actual results may differ from management’s estimates resulting in future changes in estimated liabilities. The Company estimates its claims based on its previous experience of its insurance portfolio. The provision for claims incurred but not reported (IBNR) is an estimation of claims which are expected to be reported subsequent to the date of statement of financial position, for which the insured event has occurred prior to the date of statement of financial position. The primary technique adopted by management in estimating the cost of notified and IBNR claims, is that of using the past claims settlement trends to predict future claims settlement trends. Claims requiring court or arbitration decisions, if any, are estimated individually. The Management reviews its provisions for claims incurred, and claims incurred but not reported, on a monthly basis. Any difference between the provisions at the statement of financial position date and actual settlement is included in provisions in the following year in the statement of income for that year. The provision for outstanding claims, as at 31 December, is also verified by an independent actuary.A range of methods such as the Chain Ladder Method, the Bornhuetter-Ferguson Method and the Expected Loss Ratio Method are used by the actuaries to determine these provisions. Also, the Actuaries have used a segmentation approach which includes analyzing the costs per member per year for the medical line of business. Underlying these methods are also a number of explicit or implicit assumptions relating to the expected settlement amount and the settlement patterns of the claims.Estimation of premium deficiency for medical insurance is highly sensitive to a number of assumptions as to the future events and conditions. It is based on an expected loss ratio for the unexpired portion of the risks for active written policies. To arrive at the estimate of the expected loss ratio, the company’s actuarial team, and also the independent actuary, consider the claims and premiums relationship which is expected to apply on a month-to-month basis, and ascertain, at the end of the financial period, whether a premium deficiency reserve is required.ii)Impairment of receivablesA provision for impairment of receivables and reinsurance receivables is established when there is an objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtors, probability that the debtors will enter into bankruptcy or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired.iii)Deferred acquisition costs Acquisition costs related to the sale of new policies are recorded as deferred acquisition costs and are amortised in the statement of income over the period of policy coverage. If the assumptions relating to future profitability of these policies are not realised, the amortisation of these costs could be accelerated and this may also require additional impairment write-offs in the statement of income.iv)Useful lives of Fixtures, Furniture and Right-of-use assets The Company's management determines the estimated useful lives of its Fixtures, Furniture and Right-of-use assets for calculating depreciation. These estimates are determined after considering the expected usage of the assets or physical wear and tear. Management reviews residual values and useful lives annually and future depreciation charges are adjusted where management believes the useful lives differ from previous estimates.v)Fair value of financial instrumentsThe fair value for financial instruments traded in active markets at the reporting date is based on their quoted market price. Where the fair values of financial assets and financial liabilities recorded on the statement of financial position cannot be derived from active markets, they are determined using a variety of valuation techniques that include the use of mathematical models. The inputs to these models are derived from observable market data where possible, but if this is not available, judgment is required to establish fair values.vi)Impairment of available for sale investments The Company exercises judgment to consider impairment on the available for sale investments at each reporting date. This includes determination of a significant or a prolonged decline in the fair value of equity securities below cost. The determination of what is 'significant' or 'prolonged' requires judgment. In making this judgment, the Company evaluates among other factors, the normal volatility in share prices. In addition, the Company considers impairment to be appropriate when there is evidence of deterioration in the financial health of the investee, industry and sector performance, changes in technology, and operational & financing cash flows. The Company considers 30% or more, as a reasonable measure for significant decline below its cost, irrespective of the duration of the decline, which is recognised in the statement of income as an impairment charge on investments. A prolonged decline represents a decline below cost that persists for 1 year or longer irrespective of the amount and is recognised in the statement of income accordingly as an impairment charge on investments. The previously recognised impairment loss in respect of equity investments cannot be reversed through the statement of income. The Company reviews its debt securities classified as available for sale at each reporting date to assess whether they are impaired. vii)Going concernThe Company’s management has made an assessment of its ability to continue as a going concern and is satisfied that it has the resources to continue in business for the foreseeable future. Furthermore, management is not aware of any material uncertainties that may cast significant doubt upon the Company’s ability to continue as a going concern. Therefore, the financial statements continue to be prepared on the going concern basis.viii)Impairment of GoodwillThe Company tests whether goodwill has suffered any impairment on an annual basis. For the 2021 and 2020 reporting periods, the recoverable amount of the cash-generating units (CGUs) was determined based on value-in-use calculations which require the use of assumptions. The calculations use cash flow projections based on financial budgets approved by management covering a three-year period. Cash flows beyond the three-year period are extrapolated using the estimated growth rates stated in note 4. These growth rates are consistent with forecasts included in industry reports specific to the industry in which each CGU operates.Goodwill is initially measured at cost being the excess of the net fair value of the identifiable assets and liabilities acquired. Following initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is reviewed for impairment, annually or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. Impairment for goodwill is determined by assessing the recoverable amount of the cash generating unit (or a group of cash generating units) to which the goodwill is related. When the recoverable amount of the cash-generating unit (or a group of cash generating units) is less than the carrying amount of the cash generating unit (or a group of cash generating units) to which goodwill has been allocated, an impairment loss is recognised. Impairment losses relating to goodwill cannot be reversed in future periods. The recoverable amount is the greater of its value in use or fair value less cost to sell. In assessing the value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risk specific to the asset.	2.D
Disclosure of functional and presentation currency [text block]	These financial statements are presented in Saudi Arabian Riyals (SR), which is the Company’s functional currency. All financial information presented in SR has been rounded off to the nearest thousand except where otherwise indicated.	2.B
Disclosure of going concern [text block]	These financial statements are presented in Saudi Arabian Riyals (SR), which is the Company’s functional currency. All financial information presented in SR has been rounded off to the nearest thousand except where otherwise indicated.	2.A
Disclosure of other general disclosures about reporting entity [text block]	The Company follows a fiscal year ending on 31 December.	2.C
Disclosure of summary of significant accounting policies [abstract]
Description of accounting policy for cash and cash equivalents [text block]	Cash and cash equivalents consist of bank balances and term deposits that have original maturity periods not exceeding three months from the date of acquisition.	3.B-2
Description of accounting policy for premiums/ contributions and insurance/ reinsurance or takaful/ retakaful balance receivables [text block]	Premiums receivable are stated at gross written premiums receivable from insurance contracts, less an allowance for any uncollectible amounts. An allowance for uncollectible amount is established when there is an objective evidence that the Company will not be able to collect all amounts due according to their original terms. Bad debts are written off as incurred. Subsequent recoveries of amounts previously written off are credited in the statement of income.	3.B-3
Description of accounting policy for deferred policy acquisition costs [text block]	Commission and incremental direct costs incurred in relation to the acquisition and renewal of insurance contracts are deferred. The deferred acquisition costs are subsequently amortised over the terms of the insurance contract as premiums are earned and reported in the statement of income. Changes in the contractual useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortisation period and are treated as a change in accounting estimate. If the assumptions relating to future profitability of these policies are not realised, the amortisation of these costs could be accelerated and this may also require additional impairment write-offs in the statement of income. Deferred policy acquisition costs are also considered in the liability adequacy test for each reporting year.	3.B-4
Description of accounting policy for intangible assets and goodwill [text block]	Intangible assets Separately acquired intangible assets (software) are shown at historical cost. They have a finite useful life and are subsequently carried at cost less accumulated amortisation and impairment losses. The Company amortises intangible assets with a limited useful life using straight-line method over the following periods:YearsIT development and software3to 7GoodwillGoodwill is initially measured at excess of the fair value of the consideration paid over the fair value of the identifiable assets and liabilities acquired. Following initial recognition, goodwill is measured at cost less any accumulated impairment losses. Goodwill is reviewed for impairment, annually or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. Impairment for goodwill is determined by assessing the recoverable amount of the cash generating unit (or a group of cash generating units) to which the goodwill is related. When the recoverable amount of the cash-generating unit (or a group of cash generating units) is less than the carrying amount of the cash generating unit (or a group of cash generating units) to which goodwill has been allocated, an impairment loss is recognised in the statement of income. Impairment losses relating to goodwill cannot be reversed in future periods.	3.B-8+9
Description of accounting policy for property and equipment [text block]	Fixtures and Furnitures are initially recorded in the statement of financial position at cost. Subsequent measurement is carried out at cost less accumulated depreciation and any impairment in value. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. The estimated useful lives of the assets for the calculation of depreciation are as follows:YearsLeasehold Improvements (civil, construction work and fixtures)15 years or lease termFixtures, Furniture and Right-of-use assets5 to 20 Computer and IT equipment and infra-structure 2.5 to 7Motor vehicles 4Residual values, useful lives and the methods of depreciation are reviewed and adjusted as appropriate at each financial year end. Impairment reviews take place when events or changes in circumstances indicate that the carrying value may not be recoverable. The depreciation charge for the year is recognised in the statement of income on an actual basis. Similarly, impairment losses, if any, are recognised in the statement of income. Expenditure for repairs and maintenance is charged to the statement of income. Subsequent expenditure is capitalised only if it is probable that the future economic benefits associated with the expenditure will flow to the Company. Gain / loss on sale of Fixtures, Furniture and Right-of-use assets is included in statement of income.	3.B-7
Description of accounting policy for liability adequacy test [text block]	At each reporting date the Company assesses annually whether its recognised insurance liabilities are adequate using current estimates of future cash flows under its insurance contracts. If that assessment shows that the carrying amount of its insurance liabilities is inadequate in the light of estimated future cash flows, the entire deficiency is immediately recognised in the statement of income and an unexpired risk provision is created.	3.B-10
Description of accounting policy for accounts payable and accruals [text block]	Liabilities are recognised for amounts to be paid in the future for goods or services received, whether billed by the supplier or not.	3.B-11
Description of accounting policy for provisions [text block]	Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the obligation amount.	3.B-12
Description of accounting policy for statutory reserve [text block]	In accordance with the Company’s by-laws, the Company shall allocate 20% of its net income from shareholders operations each year to the statutory reserve until it has built up a reserve equal to the share capital. The reserve is not available for distribution.	3.B-30
Description of accounting policy for employees end of service benefits [text block]	Accruals are made at the present value of expected future payments in respect of services provided by the employees up to the end of the reporting period using the projected unit credit method. Consideration is given to the expected future wages and salary levels, experience of employee departures and periods of service. Expected future payments are discounted using market yields at the end of the reporting period of high-quality corporate bonds with terms and currencies that match, as closely as possible, the estimated future cash outflows. The benefit payments obligation is discharged as it falls due. Re-measurement (actuarial gains / losses) as a result of experience adjustments and changes in actuarial assumptions are recognised in the statement of other comprehensive income.	3.B-13
Description of accounting policy for impairment and uncollectibiity of financial assets [text block]	The Company assesses at each reporting date, whether there is any objective evidence that a financial asset or a group of financial assets is impaired. A financial asset or a group of financial assets is deemed to be impaired if, and only if, there is an objective evidence of impairment as a result of one or more events that have occurred after the initial recognition of the asset (an incurred loss event) and that loss event (or events) has an impact on the estimated future cash flows of the financial asset or the group of financial assets that can be reliably estimated. If such evidence exists, an impairment loss is recognised in the statement of income. Evidence of impairment may include indications that the debtors or a group of debtors is experiencing a significant financial difficulty, default or delinquency in repayments, the probability that they will enter bankruptcy or other financial reorganisation and observable data indicating that there is a measurable decrease in the estimated future cash flows, such as changes in arrears or economic conditions that correlate with defaults. Impairment is determined as follows:(a)For assets carried at cost, impairment is the difference between carrying value and the present value of future cash flows discounted at the current market rate of return for a similar financial asset; and(b)For assets carried at amortised cost, impairment is the difference between the carrying amount and the present value of future cash flows discounted at the original effective commission rate.For impaired available for sale securities any subsequent increase in fair value of these impaired securities is recognised in the statement of other comprehensive income and recorded in the investment fair value reserve unless this increase represents a decrease in the impairment loss that can be objectively related to an event occurring after the impairment loss was recognised in the statement of income. In such an event, the reversal of the impairment loss is recognised as a gain in the statement of income. Impairment relating to investments in available-for-sale equity instruments are not reversed through profit or loss.	3.B-15
Description of accounting policy for cash dividend and non-cash distribution to equity holders [text block]	The Company recognises a liability to make cash distributions to shareholders of the Company when the distribution is authorised and is no longer at the discretion of the Company. A distribution is authorised when it is approved by the shareholders and SAMA. A corresponding amount is recognised directly in equity.	3.B-29
Description of accounting policy for reinsurance premium/ retakaful contributions [text block]	Reinsurance premiums ceded are recognised as a reduction in net written premium when payable. Reinsurance premiums are charged to income over the terms of the policies to which they relate on a pro-rata basis.	3.B-19
Description of accounting policy for reinsurance/ retakaful activities [text block]	In order to optimise financial exposure from large claims, the Company enters into reinsurance agreements with local and internationally reputable reinsurers. Claims receivable from reinsurers are estimated in a manner consistent with the claim liability and in accordance with the reinsurance contracts. These amounts, if any, are shown as “Reinsurers’ share of outstanding claims” in the statement of financial position until the claim is agreed and paid by the Company. Once the claim is paid, the amount due from the reinsurers in connection with the paid claim is transferred to amounts due from / (to) reinsurers.At each reporting date, the Company assesses whether there is any indication that a reinsurance asset may be impaired. Where an indicator of impairment exists, the Company makes a formal estimate of recoverable amount. Where the carrying amount of a reinsurance asset exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.	3.B-22
Description of accounting policy for investment income [text block]	(a)Financial assets at fair value through statement of income Investments are classified as at fair value through statement of income if they are classified as held-for-trading or are designated as such on initial recognition. The investments in sukuks, equities and mutual funds are held for trading and accordingly are classified as FVSI. Directly attributable transaction costs are recognised in the statement of income as incurred. Subsequently, such investments are re-measured at fair value, with all changes in fair value being recorded in the statement of income. (b)Available for sale investmentsAvailable for sale investments are non-derivative investments that are designated as available for sale or not classified as another category of financial assets, and are intended to be held for an unspecified period of time, which may be sold in response to needs for liquidity or changes in special commission rates, exchange rates or equity prices.Investments which are classified as available for sale are initially recognised at fair value including direct and incremental transaction costs and subsequently measured at fair value except for unquoted equity securities where fair value cannot be reliably measured are carried at cost. Any unrealised gains or losses arising from changes in fair value are recognised through the statement of comprehensive income until the investments are derecognised or impaired whereupon any cumulative gains or losses previously recognised in equity are reclassified to statement of income for the period and are disclosed as gains/(losses) on non-trading investments.(c)Held to maturity investmentsHeld to maturity investments are investments having fixed or determinable payments and fixed maturity that the management has the positive intention and ability to hold to maturity are classified as held to maturity. Investments are initially recognised at fair value including direct and incremental transaction cost. Subsequent to initial measurement, these are measured at amortised cost less impairment losses, if any.	3.B-5
Description of accounting policy for claims/ benefits [text block]	Claims, comprising amounts payable to medical providers and other third parties are charged to income as incurred. Claims comprise the estimated amounts payable, in respect of claims reported to the Company and those not reported at each reporting date.The Company estimates its claims based on previous experience. In addition, a provision based on the management’s judgment and the Company’s prior experience is maintained for the cost of settling claims incurred but not reported at each reporting date. Any difference between the provisions at the statement of financial position date and actual settlement is included in provisions in the following year in the statement of income for that year. The Company does not discount its liability for unpaid claims as substantially all claims are expected to be paid within one year of the statement of financial position date.	3.B-20
Description of accounting policy for general insurance/ takaful contracts [text block]	Insurance contracts are those contracts where the Company (the insurer) has accepted significant insurance risk from another party (the policyholders) by agreeing to compensate the policyholders if a specified uncertain future event (the insured event) adversely affects the policyholders. As a general guideline, the Company determines whether it has significant insurance risk by comparing benefits paid with benefits payable if the insured event did not occur.Once a contract has been classified as an insurance contract, it remains an insurance contract for the remainder of its lifetime, even if the insurance risk reduces significantly during this period, unless all rights and obligations are extinguished or expired.	3.B-21
Description of accounting policy for impairment of non-financial assets [text block]	The Company assesses at each reporting date whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset’s recoverable amount. An asset’s recoverable amount is the higher of an asset’s or cash-generating unit’s (CGU) fair value less costs to sell and its value in use and is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. In determining fair value less costs to sell, recent market transactions are taken into account, if available. If no such transactions can be identified, an appropriate valuation model is used. These calculations are corroborated by valuation multiples, quoted share prices or other available fair value indicators. The Company bases its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Company’s CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of three to five years. For longer periods, a long-term growth rate is calculated and applied to project future cash flows after the fifth year.Impairment losses of continuing operations are recognised in the statement of income.For assets, excluding goodwill, an assessment is made at each reporting date whether there is any indication that previously recognised impairment losses may no longer exist or may have decreased. If such indication exists, the Company estimates the asset’s recoverable amount. A previously recognised impairment loss is reversed only if there has been a change in the assumptions used to determine the asset’s recoverable amount since the last impairment loss was recognised. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognised for the asset in prior years. Such reversal is recognised in the statement of income.	3.B-16
Description of accounting policy for other revenue recognition [text block]	Premiums earnedThe Company only issues short-term insurance contracts for providing health care services (‘medical insurance’) in Saudi Arabia. Premiums are taken to income over the terms of the policies to which they relate on a pro-rata basis based on 365th method. Unearned premiums represent the portion of premiums written relating to the unexpired period of coverage. The change in the provision for unearned premiums is taken to the statement of income.Investment and commission income Investment income or loss comprises of unrealised and realised gains and losses on investments. Commission income on term deposits is recognised using the effective interest method in the statement of income.	3.B-18
Description of accounting policy for expenses [text block]	Selling and marketing expenses are those which specifically relate to salesmen, sales promotion, advertisements, regulatory levies, trademark fees and fulfillment costs. All other expenses are classified as general and administration expenses.	3.B-23
Description of accounting policy for share based payments [text block]	يتم قياس تكلفة معاملات تسوية أسهم الموظفين بالرجوع إلى قيمها العادلة في تاريخ المنح. تاريخ المنح هو التاريخ الذي يتفق عليه كل من المنشأة والموظف على اتفاقية الدفع على أساس الأسهم، مع وجود تفاهم مشترك بين المنشأة والطرف المقابل على شروط وأحكام الاتفاق. يتم إدراج تكلفة معاملة تسوية الاسهم -إضافة إلى زيادة مقابلة في الاسهم كإحتياطي للدفع على أساس الأسهم -على مدى فترة الوفاء بالأداء و/أو شروط الخدمة والتي تنتهي في تاريخ أحقية العاملين الكاملة للمكافأة ("تاريخ المنح"). تعكس المصروفات المتراكمة المحققة لمعاملات تسوية الاسهم في تاريخ كل تقرير مالي وحتى تاريخ المنح مدى انتهاء صلاحية فترة المنح وأفضل تقدير للشركة ولعدد أدوات حقوق الملكية التي سيتم منحها في النهاية. يمثل المصروف الذي يتم تحميله أو عكسه في قائمة الدخل لفترة مالية حركة المصروفات المتراكمة المسجلة في بداية ونهاية تلك الفترة. وفي حالات احتجاز تلك المكافأة (مثلاً عندما لا يتم استيفاء شروط المنح ذات العلاقة) تقوم الشركة بعكس المصروفات ذات العلاقة بتلك المِنَح والتي سبق إدراجها في قائمة الدخل. وحيثما يتم إلغاء المكافأة بالأسهم (وليس احتجاز المكافأة)، فإنها تعامل وكأنها مُنحت في تاريخ الإلغاء ويتم الإدراج الفوري لأي مصروف لم يتم تسجيله بعد بخصوص المكافأة.إن قيمة الأسهم المعاد شرائها بما في ذلك التكاليف المرتبطة بعملية الشراء، يتم ادراجها كخصم من حقوق الملكية.	3.B-14
Description of accounting policy for segment reporting [text block]	An operating segment is a component of an entity:-that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); and-whose operating results are regularly reviewed by the entity’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and-for which discrete financial information is available.	3.B-24
Description of accounting policy for accounting of leases [text block]	Right of Use AssetsThe Company recognises Right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use).Company applies cost model, and measure right of use asset at cost;1. less any accumulated depreciation and any accumulated impairment losses; and 2. adjusted for any re-measurement of the lease liability for lease modificationsUnless the Company is reasonably certain to obtain ownership of the leased asset at the end of the lease term, Generally, right of use asset would be equal to the lease liability. However, if there are additional costs such as site preparation, non-refundable deposits, application money, other expenses related to transaction etc. it needs to be added to the right of use asset value.The recognised Right-of-use assets are depreciated on a straight-line basis over the shorter of its estimated useful life and the lease term. Right-of-use assets are subject to impairment. Lease LiabilitiesOn initial recognition, the lease liability is the present value of all remaining payments to the lessor, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate. After the commencement date, Company measures the lease liability by:1. Increasing the carrying amount to reflect interest on the lease liability.2. Reducing the carrying amount to reflect the lease payments made and;3. Re-measuring the carrying amount to reflect any re-assessment or lease modification. The lease liability is measured at amortized cost using the effective interest method. It is re-measured when there is a change in future lease payments arising from a change in an index or rate, if there is a change in the Company's estimate of the amount expected to be payable under a residual value guarantee, or if the Company changes its assessment of whether it will exercise a purchase, extension or termination option.When the lease liability is re-measured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.Short-term leases and leases of low-value assetsThe Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets, including IT equipment. The Company recognizes the lease payments associated with these leases as an expense on a straight-line basis over the lease term.	3.B-25
Description of accounting policy for foreign currencies [text block]	The accounting records of the Company are maintained in Saudi Riyals. Transactions in foreign currencies are recorded in Saudi Riyals at the approximate rate of exchange ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the spot rate at the reporting date. All differences are taken to the statement of income.	3.B-27
Description of accounting policy for derivative financial instruments and hedges [text block]	Financial instruments – initial recognition and subsequent measurementFinancial instruments comprise financial assets and financial liabilities.Financial assets consist of cash and cash equivalents, premiums receivable, investments, term deposits, statutory deposit and other receivables. Financial liabilities consist of insurance operations surplus payable, amounts due to related parties, and certain other liabilities.Date of recognitionRegular way sale and purchase of financial instruments is recognised on the trade date, i.e., the date that the Company becomes a party to the contractual provisions of the instrument. Regular way purchases or sales are purchases or sales of financial instruments that require settlement of instrument within the time frame generally established by regulation or convention in the market place.Measurement of financial instrumentsAll financial instruments are measured initially at their fair value plus, in the case of financial assets and financial liabilities not at fair value through statement of income, any directly attributable incremental costs of acquisition or issue. The classification of financial instruments at initial recognition depends on the purpose for which the financial instruments were acquired and their characteristics. Subsequent to initial measurement, financial instruments are carried at amortised cost except for FVSI and AFS investments which are carried at fair value.De-recognition Financial assetA financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is derecognised when:the rights to receive cash flows from the asset have expired; orthe Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a ‘pass-through’ arrangement; and either (a) the Company has transferred substantially all the risks and rewards of the asset, or (b) the Company has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.When the Company has transferred its rights to receive cash flows from an asset or has entered into a ‘pass-through’ arrangement, it evaluates if and to what extent it has retained the risks and rewards of ownership. When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the asset, the asset is recognised to the extent of the Company’s continuing involvement in the asset. In that case, the Company also recognises an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained. Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Company could be required to repay.Financial liabilityA financial liability is derecognised when the obligation under the liability is discharged, cancelled or expired.	3.B-1+17
Description of accounting policy for off setting financial assets and liabilities [text block]	Financial assets and financial liabilities are offset and the net amount is reported in the statement of financial position only when there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis, or to realise the assets and settle the liabilities simultaneously. Income and expenses are not offset in the statement of income unless required or permitted by any accounting standard or interpretation, as specifically disclosed in the accounting policies of the Company.	3.B-28
Description of accounting policy for time (murabaha) deposit [text block]	Term deposits, with original maturity of more than three months, are initially recognised in the statement of financial position at fair value and are subsequently measured at amortised cost using the effective interest method, less any impairment in value.	3.B-6
Disclosure of notes forming part of accounts [abstract]
Disclosure of property and equipment [text block]	10.1 FIXTURES, FURNITUREOffice, furniture,and fixturesComputerequipmentMotor vehiclesLeasehold improvementsCapital work in progressTotal2021 SR’000Cost:At 1 January 202186,23260,00540442,5722,764191,977Additions during the year --52 ----9,0639,115Transferred during the year8627,661 --832(9,355)--Disposals during the year (44)(338)--(3,969)--(4,351)At 31 December 202187,05067,38040439,4352,472196,741Accumulated depreciation:At 1 January 2021(63,166)(40,835) (161) (9,422) --(113,584) Charge for the year(5,062)(5,985)(101)(4,068)--(15,216)Disposal7330--1,493--1,830At 31 December 2021(68,221)(46,490) (262) (11,997) --(126,970)Net book value:At 31 December 202118,82920,890142 27,438 2,472 69,771Office, furniture,and fixtures ComputerequipmentMotor vehiclesLeasehold improvementsCapital work in progressTotal2020 SR’000Cost:At 1 January 202085,82846,16740441,0396,699180,137Additions during the year --2,892----8,94811,840Transferred during the year 404 10,946--1,533 (12,883)--At 31 December 202086,23260,00540442,5722,764191,977Accumulated depreciation:At 1 January 2020(57,194)(35,703)(60)(5,361)--(98,318)Charge for the year(5,972)(5,132)(101)(4,061)--(15,266)At 31 December 2020(63,166)(40,835) (161) (9,422) --(113,584) Net book value:At 31 December 202023,06619,170 243 33,150 2,764 78,393 10.2 RIGHT-OF-USE ASSETS The movement of Right-of-use assets are as follows:20212020 SAR’000SAR’000As at 1 January125,62687,622Additions during the year 2,92954,245Amortisation during the year (15,939) (16,241) As at 31 December 112,616125,626	10
Disclosure of investments [text block]	Investments are classified as follows:20212020Insurance operationsShareholders’ operationsTotalInsurance operationsShareholders’ operationsTotalSR’000Held as FVSI 1,808,1991,449,7363,257,935 2,869,628 825,133 3,694,761 Available-for-sale 691,2301,423,3582,114,588 698,553 1,504,882 2,203,435 Held to maturity 100,000231,250331,250--131,250131,2502,599,4293,104,3445,703,773 3,568,181 2,461,265 6,029,446 (i)Investments held as FVSI comprise of the following:2021Insurance operations Shareholders’ operationsDomesticInternationalDomesticInternationalTotalSR’000Sukuks18,014--55,045--73,059Funds1,782,875 7,3101,372,761 21,9303,184,8761,800,889 7,3101,427,80621,9303,257,9352020Insurance operations Shareholders’ operationsDomesticInternationalDomesticInternationalTotalSR’000Sukuks18,025--55,079--73,104Funds2,843,9857,618747,19922,8553,621,6572,862,0107,618802,27822,8553,694,761(ii)Available-for-sale investments comprise of the following:2021Insurance operations Shareholders’ operationsDomesticInternationalDomesticInternationalTotalSR’000Sukuks470,858183,613 793,312105,726 1,553,509 Funds -- 36,759127,646 17,287 181,692 Equities -- -- 316,82612,372329,198Investments in discretionary portfolios -- -- 50,189 -- 50,189470,858220,3721,287,973 135,3852,114,588(iii)Available-for-sale investments comprise of the following (continued):2020Insurance operations Shareholders’ operationsDomesticInternationalDomesticInternationalTotalSR’000Sukuks422,351 238,029 900,236 147,710 1,708,326 Funds-- 38,173 107,501 7,111 152,785 Equities----228,716 5,625 234,341 Investments in discretionary portfolios----107,983 --107,983422,351276,2021,344,436160,4462,203,435(iv)Held to maturity investments comprise of the following:2021Insurance operations Shareholders’ operationsDomesticInternationalDomesticInternationalTotalSR’000Sukuks100,000--156,25075,000331,250100,000--156,25075,000331,2502020Insurance operations Shareholders’ operationsDomesticInternationalDomesticInternationalTotalSR’000Sukuks----131,250--131,250----131,250--131,250The movements in the investments balance are as follows:i.Held as FVSI2021Insurance operationsShareholders’ operationsTotalSR’000Balance at the beginning of the year2,869,628 825,133 3,694,761Purchases during the year7,880,1306,741,192 14,621,322Disposals during the year(8,944,090)(6,116,701)(15,060,791)Unrealised gains during the year, net2,5311122,6431,808,199 1,449,736 3,257,9352020Insurance operationsShareholders’ operationsTotalSR’000Balance at the beginning of the year161,548107,968 269,516 Purchases during the year9,476,7213,295,447 12,772,168Disposals during the year(6,769,701) (2,578,100) (9,347,801)Unrealised gains/(losses) during the year, net1,060 (182)8782,869,628825,1333,694,761 i.Available-for-sale investments2021Insurance operationsShareholders’ operationsTotalSR’000Balance at the beginning of the year698,553 1,504,882 2,203,435Purchases during the year152,630 192,166344,796Maturity during the year(144,870)(335,475)(480,345)Unrealised (losses)/gains during the year, net(15,083)61,78546,702691,2301,423,3582,114,5882020Insurance operationsShareholders’ operationsTotalSR’000Balance at the beginning of the year564,003876,0631,440,066Purchases during the year289,000687,693976,693Maturity during the year(166,004)(215,685)(381,689)Unrealised gains during the year, net11,554156,811168,365698,5531,504,8822,203,435ii.Held to maturity investments2021Insurance operationsShareholders’ operationsTotalSR’000Balance at the beginning of the year--131,250131,250Purchases during the year100,000100,000200,000100,000231,250331,250iii.Held to maturity investments (continued)2020Insurance operationsShareholders’ operationsTotalSR’000Balance at the beginning of the year--131,250131,250Purchases during the year--------131,250131,250	7
Disclosure of investments held-to-maturity [text block]	The term deposits are held with reputable commercial banks and financial institutions. These deposits are predominantly in Murabaha structure with a small allocation in Mudaraba structure. The term deposits are classified as held to maturity investments. They are mostly denominated in Saudi Arabian Riyals and have an original maturity of more than three months to more than one year (2020: three months to more than one year) and yield financial income at rates ranging from 0.95% to 4.30% per annum (2020: 1.2% to 4.30% per annum). The movements in term deposits during the year ended 31 December 2021 are as follows:2021 Insurance operationsShareholders’ operationsTotalSR’000Balance at beginning of the year1,645,2921,151,2552,796,547Matured during the year(1,507,552)(466,960)(1,974,512)Commission income earned during the year31,182 27,17558,357Placed during the year1,839,000374,3282,213,3282,007,922 1,085,798 3,093,7202020Insurance OperationsShareholders’ operationsTotalSR’000Balance at beginning of the year3,407,0551,747,2555,154,310Matured during the year(2,330,514)(936,277)(3,266,791)Commission income earned during the year79,90140,277120,178Placed during the year488,850300,000788,8501,645,2921,151,2552,796,547	9
Disclosure of deferred policy acquisition costs [text block]	20212020SR’000SR’000Balance at beginning of the year68,214134,022Deferred during the year476,255564,926Amortisation for the year(343,427)(630,734)201,04268,214	14
Disclosure of premiums/ contributions and insurance/ reinsurance or takaful/ retakaful balance receivables [text block]	Receivable amounts are due from the following: 20212020SR’000SR’000Policyholders 1,401,823 1,159,253Brokers 590,833 383,314 1,992,656 1,542,567Provision for doubtful receivables (231,356)(222,524)Premiums receivable – net 1,761,300 1,320,043 Movement in provision for doubtful debts during the year was as follows:20212020SR’000SR’000Balance at the beginning of the year222,524197,187Provision made during the year 22,45828,770Write-offs during the year(13,626)(3,433)Balance at end of the year231,356222,524The aging analysis of premiums receivable - net arising from insurance contracts is as follows:2021Not past dueUp to three months Above three and up to six monthsAbove six and up to twelve monthsAbove twelve months SR’000Policyholders829,825262,29063,75654,340--1,210,211Brokers 395,183126,79022,9246,192--551,0891,225,008389,08086,68060,532--1,761,3002020Not past dueUp to three months Above three and up to six monthsAbove six and up to twelve monthsAbove twelve months SR’000Policyholders389,768481,84289,35914,2131,835977,017Brokers222,02752,70557,1968,3922,706343,026611,795534,547146,55522,6054,5411,320,043Unimpaired receivables are estimated, on the basis of past experience, to be fully recoverable. It is not the practice of the Company to obtain collateral over receivables.The Company only enters into insurance and reinsurance contracts with recognised, creditworthy parties. It is the Company’s policy that all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivables are monitored on an ongoing basis in order to reduce the Company’s exposure to bad debts.The five largest customers account for 13.22% (31 December 2020: 18.8%) of the premiums receivable as at 31 December 2021.	6
Disclosure of prepayments and other assets [text block]	Prepaid expenses and other assets comprise of the following:2021 2020Insurance operationsShareholders’ operationsTotalInsurance operationsShareholders’ operationsTotalSR’000Prepayments54,034--54,03448,529--48,529Accrued income7,63513,25620,8916,12213,91920,041Other receivables 38,329--38,32916,516--16,51699,99813,256113,25471,16713,91985,086	8
Disclosure of cash and cash equivalents [text block]	Cash and cash equivalents consist of the following:2021 Insurance operationsShareholders’ operationsTotalSR’000Bank balances430,30030,067460,367Term Deposits 500,391--500,391930,69130,067960,7582020Insurance operationsShareholders’ operationsTotalSR’000Bank balances195,232438,019633,251195,232438,019633,251The amount payable to / receivable from shareholders’ operations is settled by transfer of cash at each reporting date. During the year ended 31 December 2021, the insurance operations transferred cash of SR 435.3 million to the shareholders’ operations (31 December 2020: SR 142 million).	5
Disclosure of statutory deposit [text block]	As required by SAMA Insurance Regulations, the Company deposited an amount equivalent to 10% of its paid-up share capital, amounting to SR 120 million (2020: SR 120 million), in a bank designated by SAMA. Accrued income on this deposit is payable to SAMA amounting to SR 14.9 million (2020: SR 13.8 million) and this deposit cannot be withdrawn without approval from SAMA.	12
Disclosure of employees' end of service benefits [text block]	Accruals are made in accordance with the actuarial valuation under the projected unit credit method while the benefit payments obligation is discharged as and when it falls due. The amounts recognised in the statement of financial position and movement in the obligation during the year based on its present value are as follows:1Movement of end-of-service benefits 20212020SR’000SR’000Balance at the beginning of the year140,01296,341Current service costs24,25123,163Finance costs3,2444,131Actuarial (gains)/losses (7,535)20,700Benefits paid during the year(7,686)(4,323)Balance at the end of the year152,286 140,0122Principal actuarial assumptionsThe following range of significant actuarial assumptions was used by the Company for the valuation of end-of-service benefits:20212020Valuation discount rate2.65%2.45%Expected rate of increase in salary level across different age bands4.5%4.5%Employee turnover rate13%11%Mortality rate0.06%0.06%The impact of changes in sensitivities on present value of employees’ end-of-service ((Increase)/Decrease) benefits is as follows:20212020SR’000SR’000Valuation discount rate-Increase by 0.5%6,8836,521-Decrease by 0.5%(7,423)(7,046)Expected rate of increase in salary level across different age bands-Increase by 1%(15,046)(14,259)-Decrease by 1%13,21612,482Mortality rate-Increase by 50%(66)(74)-Decrease by 50%6674Employee turnover-Increase by 20%3,3223,501-Decrease by 20%(3,427)(3,634)The average duration of the employees’ end-of-service benefits at the end of the reporting period is 10.6 years, (2020: 10.9 years)	21
Disclosure of reinsurance/ retakaful balance payable [text block]	Reinsurance payable represents amounts payable to reinsurers of SR 25.4 million (2020: SR 4.9 million), for the excess of loss (XOL) reinsurance contract.	25
Disclosure of accrued expenses and other liabilities [text block]	1 Accrued and other liabilities comprise of the following:20212020Insurance operationsShareholders’ operationsTotalInsurance operationsShareholders’ operationsTotalSR’000Accrued expenses200,2496,863207,112282,9026,249289,151VAT payable85,516--85,51623,254--23,254Advances from policyholders 80,578--80,57852,583--52,583VAT payable to providers170,708--170,708121,595--121,595Other liabilities 60,860--60,86053,867--53,867597,9116,863604,774534,2016,249540,4502 Lease liabilityAs of 31 December 2021, lease liability amounted SAR 125.3 million (2020: SR 135.6 million). Below is the movement during the year:20212020SR’000SR’000Balance at the beginning of the year 135,60090,329Finance cost5,8345,244Additions during the year2,92954,245Lease settlement(19,030)(14,218)125,333135,600	18
Disclosure of zakat [text block]	3.xxvi) Zakat and income tax The income tax expense or credit for the year is the tax payable on the current year’s taxable income, based on the applicable income tax rate, adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses. The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions, where appropriate, on the basis of amounts expected to be paid to the tax authorities.Deferred Tax Deferred income tax is provided using the liability method on temporary differences arising between the carrying amounts of assets and liabilities for financial reporting purposes and amounts used for taxation purposes. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amounts of assets and liabilities using the tax rates enacted or substantively enacted at the reporting date. A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available and the credits can be utilised. Deferred tax asset is reduced to the extent that it is no longer probable that the related tax benefits will be realised. Deferred tax assets and liabilities are not recognised for temporary differences between the carrying amount and tax bases of investments in foreign operations where the Company is able to control the timing of the reversal of the temporary differences and it is probable that the differences will not reverse in the foreseeable future. Deferred tax assets and liabilities are offset where there is a legally enforceable right to offset current tax assets and liabilities and where the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the entity has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously. Current and deferred tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. 15) Zakat The Zakat payable by the Company has been calculated in accordance with Zakat regulations in Saudi Arabia.The Zakat provision for the year is based on the following:20212020SR’000SR’000Share capital (attributable to Saudi shareholders)681,000712,869Opening retained earnings, reserve and surplus1,309,5701,189,671Opening provisions313,440389,301Adjusted net income445,353519,284Fixtures, Furniture, Right-of-use assets and goodwill(201,490)(211,407)Investments (5,276,549)(5,203,315)Zakat Base(2,728,676)(2,603,597)Adjusted net income attributable to Saudi shareholders and the general public (refer () below)445,353519,284Adjusted net income has been computed on a pro-rata basis taking into consideration before and after shareholding change.The differences between the accounting profit and the Zakat base are mainly due to certain adjustments in accordance with the relevant fiscal regulations.The Zakat charge relating to the Saudi shareholders consists of:20212020SR’000SR’000Provision for zakat 65,33364,297Adjustment for prior years(24,197)--41,13664,297The movements in the Zakat provision during the year were as follows:20212020SR’000SR’000Balance at beginning of the year285,448232,444Charge for the year41,13664,297Payments made during the year(123,764)(11,293)202,820285,448Provision for zakat and income tax20212020SR’000SR’000Zakat payable (note (a) above)202,820285,448Income tax payable (note (b) above)33,79031,751236,610317,199Status of assessment The Company has filed its zakat and income tax returns for the financial years up to and including the year 2020 with the Zakat, Tax and Custom Authority (“ZATCA”). The Company has received assessments for the fiscal periods 2008 through 2018 of additional zakat, corporate income tax and withholding tax in addition to delay fines on various assessed items.In February 2021, the Company reached a settlement with ZATCA on all zakat, corporate income tax and withholding tax for the years 2008 through 2016 and 2018. All settled liabilities were provided for previously in respective year, and, hence, there is no significant financial impact on the Company. For the year 2017 assessments, the Company has escalated the matter to the General Secretariat of Tax Committees (the “GSTC”) and their review is awaited.	3.B-26 - 15.A.C.D
Disclosure of income tax [text block]	3.xxvi) Zakat and income tax The income tax expense or credit for the year is the tax payable on the current year’s taxable income, based on the applicable income tax rate, adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses. The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions, where appropriate, on the basis of amounts expected to be paid to the tax authorities.Deferred Tax Deferred income tax is provided using the liability method on temporary differences arising between the carrying amounts of assets and liabilities for financial reporting purposes and amounts used for taxation purposes. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amounts of assets and liabilities using the tax rates enacted or substantively enacted at the reporting date. A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available and the credits can be utilised. Deferred tax asset is reduced to the extent that it is no longer probable that the related tax benefits will be realised. Deferred tax assets and liabilities are not recognised for temporary differences between the carrying amount and tax bases of investments in foreign operations where the Company is able to control the timing of the reversal of the temporary differences and it is probable that the differences will not reverse in the foreseeable future. Deferred tax assets and liabilities are offset where there is a legally enforceable right to offset current tax assets and liabilities and where the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the entity has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously. Current and deferred tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. 15) Income Tax20212020SR’000SR’000Current tax charge65,78970,969Deferred tax income(1,794)(7,725)63,99563,244The reconciliation of deferred tax is as follows:20212020SR’000SR’000Opening deferred tax asset 37,941 30,216Deferred tax income1,7947,72539,73537,941The movement in the income tax provision during the year was as follows:20212020SR’000SR’000Balance at beginning of the year31,75142,265Charge for the year65,78970,969Payments made during the year(63,750)(81,483)33,79031,751Provision for zakat and income tax20212020SR’000SR’000Zakat payable (note (a) above)202,820285,448Income tax payable (note (b) above)33,79031,751236,610317,199Status of assessment The Company has filed its zakat and income tax returns for the financial years up to and including the year 2020 with the Zakat, Tax and Custom Authority (“ZATCA”). The Company has received assessments for the fiscal periods 2008 through 2018 of additional zakat, corporate income tax and withholding tax in addition to delay fines on various assessed items.In February 2021, the Company reached a settlement with ZATCA on all zakat, corporate income tax and withholding tax for the years 2008 through 2016 and 2018. All settled liabilities were provided for previously in respective year, and, hence, there is no significant financial impact on the Company. For the year 2017 assessments, the Company has escalated the matter to the General Secretariat of Tax Committees (the “GSTC”) and their review is awaited.The Company has filed its zakat and income tax returns for the financial years up to and including the year 2020 with the Zakat, Tax and Custom Authority (“ZATCA”). The Company has received assessments for the fiscal periods 2008 through 2018 of additional zakat, corporate income tax and withholding tax in addition to delay fines on various assessed items.In February 2021, the Company reached a settlement with ZATCA on all zakat, corporate income tax and withholding tax for the years 2008 through 2016 and 2018. All settled liabilities were provided for previously in respective year, and, hence, there is no significant financial impact on the Company. For the year 2017 assessments, the Company has escalated the matter to the General Secretariat of Tax Committees (the “GSTC”) and their review is awaited.	3.B-26 - 15.B.C.D
Disclosure of classes of share capital [text block]	The authorised, issued and paid-up capital of the Company is SR 1,200 million at 31 December 2021 (31 December 2020: SR 1,200 million) consisting of 120 million shares (31 December 2020: 120 million shares) of SR 10 each.The shareholding structure of the Company is as below: 20212020Holding PercentageSR’000Holding Percentage SR’000Major shareholders52.3%628,06652.3%628,066General Public47.7%571,93447.7%571,934100.0%1,200,000100.0%1,200,000The major shareholders of the Company along with their holding percentages are as below:20212020Holding PercentageSR’000Holding Percentage SR’000Bupa Investment Oversees43.25%519,00043.25%519,000Nazer Group9.05%109,0669.05%109,06652.30%628,06652.30%628,066	27
Disclosure of statutory reserve [text block]	As required by the Saudi Arabian Insurance Regulations, 20% of the shareholders’ income shall be set aside as a statutory reserve until this reserve amounts to 100% of the paid-up share capital. The Company carries out this transfer on an annual basis at 31 December. As at 31 December 2021, SR 992.2 million (31 December 2020: SR 867.1 million) had been set aside as a statutory reserve, representing 82% (31 December 2020: 72%) of the paid-up share capital.	28
Disclosure of general and administrative expense [text block]	20212020Insurance operationsShareholders’ operationsTotalInsurance operationsShareholders’ operationsTotalSR’000Employees’ costs418,898--418,898393,903--393,903Rents and maintenance costs60,171--60,17151,377--51,377Travelling expenses5,230--5,2304,192--4,192Depreciation and amortisation 45,601--45,60147,238--47,238Communication expenses12,696--12,69611,151--11,151Board expenses--5,4665,466--5,2775,277Legal and Professional Fees35,299--35,29925,24622525,471Others 8,1097,12415,23332,09214,84846,940586,00412,590598,594565,19920,350585,549	31
Disclosure of selling and marketing expenses [text block]	20212020SR’000SR’000Employees’ costs51,50847,875Marketing expenses32,25524,816Trade mark fee (see note 19)26,61126,896Others5,2726,880115,646106,467	32
Disclosure of investments income [text block]	2021 2020Insurance operationsShareholders’ operationsTotalInsurance operationsShareholders’ operationsTotalSR’000Commission income on held to maturity investments35,35535,04070,39579,09845,537124,635Commission and dividend income on available for sale investments22,92381,606104,52919,64450,89470,538Commission income on FVSI investments – net 15,8538,18224,03510,8186,47617,294Realised gains/(losses) on investment - net 8,18250,654 58,83611,170(11,218)(48)Unrealised gains on FVSI investments - net2,5301122,642 1,058(182)87684,843175,594260,437121,788 91,507213,295	33
Disclosure of technical reserve for insurance/takaful/reinsurance/retakaful operations [text block]	1 Movement in unearned premiums Movements in unearned premiums are as follows:2021GrossReinsuranceNetSR’000Balance at beginning of the year 4,023,331 (20,108) 4,003,223 Premium written/(ceded) during the year 11,382,194 (86,082) 11,296,112 Premium earned during the year (10,695,970) 78,255 (10,617,715) 4,709,555 (27,935) 4,681,620 2020GrossReinsuranceNetSR’000Balance at beginning of the year4,376,219(20,625)4,355,594Premium written/(ceded) during the year10,447,353(65,242)10,382,111Premium earned during the year(10,800,241)65,759(10,734,482)4,023,331(20,108)4,003,2232 Net outstanding claims and reservesNet outstanding claims and other technical reserves consist of the following:20212020SR’000SR’000Outstanding claims 601,168 446,519 Claims incurred but not reported1,413,888 1,378,294 Premium deficiency reserve74,602263,751Claims handling reserve21,79720,7552,111,4552,109,319Less:Reinsurers’ share of outstanding claims (7,207)(1,475)Reinsurers’ share of claims incurred but not reported (7,829)(6,461)(15,036)(7,936)Net outstanding claims and reserve2,096,4192,101,383	13
Disclosure of earnings per share [text block]	The basic and diluted earnings per share has been calculated by dividing net income after zakat and tax for the year by the weighted average number of ordinary shares issued and outstanding at year end.	34
Disclosure of related party transactions [text block]	Related parties represent major shareholders, Board members and key management personnel of the Company, and companies of which they are principal owners and any other entities controlled, jointly controlled or significantly influenced by them. Contract pricing policies and terms are conducted on an arm’s length basis and transactions approved by the Company’s management, or where required and applicable the Company’s Board of Directors. The following are the details of the major related party transactions during the year and their related balances:Related partyNature of transactionAmount of transactionsduring the yearReceivable/(payable) balance as at2021202020212020SR’000SR’000SR’000SR’000Shareholders and othersInsurance premium written215,821392,0202,726(536)ShareholdersReinsurance Premium ceded (59,358)(41,431)(19,672)(79,803)Shareholders and othersClaims paid196,241274,591(17,289)*(20,997)ShareholdersMedical costs charged by providers179,055140,333(19,696)(15,303)ShareholdersExpenses charged to/ (from) a related party-net6598691,024966ShareholdersTax equalisation – net14,241(1,873)12,369(1,873)ShareholdersBoard and committee member remuneration fees833915(833)(915)Bupa Middle East Holdings Two W.L.L. (Related party)Trademark fee (note19)26,61126,896(26,611)(26,896) Amounts due to related parties amounted to SR 33,723 thousand (2020: SR 108,521 thousand). Amounts included in premium receivables (note 6).*** Amounts are included in the outstanding claims.a.Compensation to key management personnel:2021 2020SAR’000SAR’000Salaries and allowances (note (a) below) 17,48117,836Incentives (note (b) below)25,88417,208End of Service benefits 1,0951,08844,460 36,132a)Includes the members’ direct salary related expenses, other than the incentives’ and EOS expenses.b)Includes the costs of the bonuses and the long term incentive plan. b. Board of Directors’ remuneration and related expenses 2021 2020SAR’000SAR’000Board of Directors’ remuneration 3,6483,600Board attendance fees 460300Other board and sub-committees’ expenses 1,3581,3775,4665,277	24
Disclosure of entity's operating segments [text block]	The Company only issues short-term insurance contracts for providing health care services (‘medical insurance’). All the insurance operations of the Company are carried out in the Kingdom of Saudi Arabia. For management reporting purposes, the operations are monitored in two customer categories, based on the number of members covered. Major customers represent members of large corporations, and all others are considered as non-major. Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision maker, who is responsible for allocating resources and assessing the performance of operating segments in line with the strategic decisions. No inter-segment transactions occurred during the year.Operating segments do not include shareholders’ operations of the Company.Segment results do not include investment and commission income, other income, selling and marketing expenses, and general and administration expenses.Segment assets do not include cash and cash equivalents, fixtures, furniture and right-of-use assets, term deposits, investments, prepaid expenses and other assets. Segment liabilities do not include reinsurance balance payable, accrued and other liabilities, due to shareholders’ operations, share based payment and policyholders’ share of surplus from insurance operations.Consistent with the Company’s internal reporting, operating segments have been approved by the management in respect of the Company’s activities, assets and liabilities as stated below:31 December 2021Insurance operationsOperating segments Major customers Non-major customers Total - Insurance operationsShareholders’ operationsTotalSR’000SR’000SR’000ASSETSPremiums receivable – net1,034,713726,5871,761,300--1,761,300Reinsurers’ share of unearned premiums15,35312,58227,935--27,935Reinsurers’ share of outstanding claims2,5604,6477,207--7,207Reinsurers’ share of claims incurred but not reported2,6235,2067,829--7,829Deferred policy acquisition costs114,64586,397201,042--201,042Unallocated assets5,638,0404,755,74910,393,789Total assets 7,643,3534,755,74912,399,102LIABILITIESUnearned premiums2,588,2462,121,3094,709,555--4,709,555Outstanding claims425,245175,923601,168--601,168Claims incurred but not reported1,000,536413,3521,413,888--1,413,888Premium deficiency reserve40,99933,60374,602--74,602Claims handling reserve15,4216,37621,797--21,797Unallocated liabilities813,368569,7001,383,068Total liabilities 7,634,378569,7008,204,07831 December 2020Insurance operationsOperating segments Major customers Non-major customers Total - Insurance operationsShareholders’ operationsTotalSR’000SR’000SR’000ASSETSPremiums receivable – net775,488544,5551,320,043--1,320,043Reinsurers’ share of unearned premiums11,7598,34920,108--20,108Reinsurers’ share of outstanding claims4909851,475--1,475Reinsurers’ share of claims incurred but not reported1,9594,5026,461--6,461Deferred policy acquisition costs28,52039,69468,214--68,214Unallocated assets5,479,8724,600,18210,080,054Total assets 6,896,1734,600,18211,496,355LIABILITIESUnearned premiums2,352,8841,670,4474,023,331--4,023,331Outstanding claims319,669126,850446,519--446,519Claims incurred but not reported988,089390,2051,378,294--1,378,294Premium deficiency Reserve189,01774,734263,751--263,751Claims handling reserve14,8695,88620,755--20,755Unallocated liabilities739,465721,3871,460,852Total liabilities 6,872,115721,3877,593,5022021Operating segments Major customers Non-major customers TotalSR’000REVENUESGross premiums written7,428,5023,953,69211,382,194Reinsurance premiums ceded – Local(3,286)(2,059)(5,345)Reinsurance premiums ceded – International(49,629)(31,108)(80,737)Net premiums written7,375,5873,920,52511,296,112Changes in unearned premiums – net(231,768)(446,629)(678,397)Net premiums earned7,143,8193,473,89610,617,715UNDERWRITING COSTS AND EXPENSESGross claims paid (6,420,918)(2,653,008)(9,073,926)Reinsurers’ share of claims paid15,8796,51422,393Net claims paid (6,405,039)(2,646,494)(9,051,533)Changes in outstanding claims(105,576)(49,073)(154,649)Changes in claims incurred but not reported(12,447)(23,147)(35,594)Changes in premium deficiency reserve148,01841,131189,149Changes in claims handling reserves (552)(490)(1,042)Reinsurance share of changes in outstanding claims 2,0703,6625,732Reinsurance share of changes in claims incurred but not reported6647041,368Net claims incurred(6,372,862)(2,673,707)(9,046,569)Policy acquisition costs(206,056)(137,371)(343,427)Total underwriting costs & expenses (6,578,918)(2,811,078)(9,389,996)NET UNDERWRITING INCOME 564,901662,8181,227,719OTHER OPERATING (EXPENSES)/ INCOMEAllowance for doubtful receivables (22,458)Unallocated income 298,027Unallocated expenses (714,240)Total other operating (expenses)/income(438,671)Income before surplus, zakat & income tax 789,048Income attributed to the insurance operations (transfer to surplus payable)(58,347)Income attributed to the shareholders before zakat and income tax 730,701Zakat charge (41,136)Income tax charge(63,995)NET INCOME ATTRIBUTED TO SHAREHOLDERS AFTER ZAKAT AND INCOME TAX625,570Gross Written Premium details 2021SAR’000Corporates 8,458,117Medium Enterprises 2,019,303Small Enterprises 803,492Micro Enterprises 78,920Individuals22,362Total 11,382,1942020Operating segments Major customers Non-major customers TotalSR’000REVENUESGross premiums written6,972,5633,474,79010,447,353Reinsurance premiums ceded – Local(3,691)(2,262)(5,953)Reinsurance premiums ceded – International(36,756)(22,533)(59,289) Net premiums written6,932,1163,449,99510,382,111Changes in unearned premiums – net365,443(13,072)352,371Net premiums earned7,297,5593,436,92310,734,482UNDERWRITING COSTS AND EXPENSESGross claims paid (5,878,457)(2,383,593)(8,262,050)Reinsurers’ share of claims paid14,9026,08520,987Net claims paid (5,863,555)(2,377,508)(8,241,063)Changes in outstanding claims7,872(2,603)5,269Changes in claims incurred but not reported(142,227)(78,639)(220,866)Changes in premium deficiency reserve(189,017)(74,734)(263,751)Changes in claims handling reserves (1,409)(854)(2,263)Reinsurance share of changes in outstanding claims (36)293257Reinsurance share of changes in claims incurred but not reported7461,7432,489Net claims incurred(6,187,626)(2,532,302)(8,719,928)Policy acquisition costs (378,440) (252,294) (630,734)Total underwriting costs & expenses (6,566,066) (2,784,596) (9,350,662)NET UNDERWRITING INCOME 731,493652,3271,383,820OTHER OPERATING (EXPENSES)/ INCOMEAllowance for doubtful receivables (28,770)Unallocated income 240,776Unallocated expenses (692,016)Total other operating (expenses)/income(480,010)Income before surplus, zakat & income tax 903,810Income attributed to the insurance operations (transfer to surplus payable)(80,141)Income attributed to the shareholders before zakat and income tax 823,669Zakat charge (64,297)Income tax charge(63,244)NET INCOME ATTRIBUTED TO SHAREHOLDERS AFTER ZAKAT AND INCOME TAX696,128Gross Written Premium details 2020SAR’000Corporates 7,904,182Medium Enterprises 1,770,054Small Enterprises 695,395Micro Enterprises 62,104Individuals15,618Total 10,447,353	23
Disclosure of capital management [text block]	For the purpose of the Company’s capital management, capital includes share capital and all other equity reserves attributable to the shareholders. Objectives are set by the Board of Directors of the Company to maintain healthy capital ratios to support its business objectives and maximise shareholders’ value. The Company manages its capital requirements by assessing shortfalls between reported and required capital levels on a regular basis. Adjustments to current capital levels are made in light of changes in market conditions and the risk characteristics of the Company’s activities. To maintain or adjust the capital structure, the Company may adjust the amount of dividends paid to shareholders or issue shares. Total capital amounted to SR 4,186,049 (31 December 2020: SR 3,878,795).In the opinion of the Board of Directors, the Company has fully complied with the regulatory capital requirements during the reported financial year. No changes were made in the objectives, policies or processes for managing capital during the years ended 31 December 2021 and 2020.	30
Disclosure of insurance/ takaful operations surplus and dividends [text block]	20212020SR’000SR’000Balance at the beginning of the year 200,391168,454Income attributable to insurance operations during the year58,34780,141Surplus paid to policyholders during the year(68,678)(48,204)Net surplus payable to policyholders190,060200,391	20
Disclosure of equity incentive plan [text block]	The Company established a share-based compensation scheme for its key management that entitles them to Bupa Arabia shares subject to successfully meeting certain service and performance conditions. Under the share-based compensation scheme, the Company manages various plans. Significant features of these plans are as follows:Maturity datesBetween March 2022 and March 2024Total number of shares granted on the grant date497,769Vesting period3-4 yearsMethod of settlementEquityFair value per share on grant dateAverage SAR 105.86	29
Disclosure of claims/ benefits development table [text block]	The following table reflects the estimated ultimate claim cost, including claims notified and incurred but not reported for each successive treatment year at each financial position date, together with the cumulative payments to date. The development of insurance liabilities provides a measure of the Company's ability to estimate the ultimate value of the claims. The Company aims to maintain adequate reserves in respect of its insurance business in order to protect against adverse future claims experience and developments. As claims develop and the ultimate cost of claims becomes more certain, adverse claims experiences will be eliminated which results in the release of reserves from earlier treatment years. In order to maintain adequate reserves, the Company transfers much of this release to the current treatment year reserves when the development of claims is less mature and there is much greater uncertainty attached to the ultimate cost of claims. By end of 2020, incurred claims were less than anticipated as the expected deferred claims from the lockdown period were deferred further to the following year, which resulted in a favourable claims experience and the release of reserves in 2021 against the surge in claims observed in the second half of the year.Treatment year – gross outstanding claims2018 and prior201920202021TotalSR ‘000Estimate of ultimate claims cost:At the end of treatment year33,980,0267,842,1558,742,0569,775,17760,339,414 One year later33,876,6227,841,1188,048,412 - 49,766,152 Two years later33,905,0757,847,016 - - 41,752,091Three years later33,909,347 - - - 33,909,347Current estimate of ultimate claims 33,909,3477,847,0168,048,4129,775,17759,579,952Ultimate payments to date33,892,9797,841,1248,037,2777,793,51657,564,896Liability recognized in the statement of financial position16,3685,89211,1351,981,6612,015,056Premium deficiency reserve74,602Claims handling provision 21,797Balance at 31 December2,111,455Treatment year – net outstanding claimsSR ‘000 Estimate of ultimate claims cost: At the end of treatment year33,789,1447,768,1958,693,4919,708,41759,959,247 One year later33,678,7997,765,3767,997,356 - 49,441,531 Two years later33,707,2967,767,317 - - 41,474,613 Three years later33,711,162- - - 33,711,162Current estimate of ultimate claims 33,711,1627,767,3177,997,3569,708,41759,184,252Ultimate payments to date33,694,8157,761,4307,986,5107,741,47757,184,232Liability recognized in the statement of financial position16,347 5,88710,8461,966,9402,000,020Premium deficiency Reserve74,602Claims handling provision 21,797Balance at 31 December2,096,419	15
Disclosure of commitments and contingencies, general [text block]	The Company’s commitments and contingencies are as follows:i)The Company is subject to legal proceedings in the ordinary course of business. There was no material change in the status of legal proceedings as at 31 December 2021.ii)As of 31 December 2021, total Letters of Guarantee issued by banks amounted to SR 128 million (2020: SR 138 million).	17
Disclosure of risk management [abstract]
Disclosure of insurance/ takaful risk [text block]	Insurance risk The Company provides short-term health insurance contracts in Saudi Arabia. Accordingly, the main insurance Risk within the Company is the claims reserve risk resulting from fluctuations in the estimated ultimate claims. The Company seeks to manage this through close monitoring of the claims’ trend and payments’ pattern to ensure that sufficient reserves are available to cover claim liabilities. The Company also have an external actuary to perform quarterly independent reviews of the reserves adequacy.The Company has a reinsurance arrangement to reduce its exposure through transfer of risk. The reinsurance agreement is an excess of loss treaty per person per claim on losses occurring basis. i)The ultimate liability arising from claims made under insurance contractsClaims reserves which are key components of the Company’s ultimate liability are estimated amounts of the outstanding claims, incurred but not reported claims (“IBNR”) and claims handling provisions. These reserves do not represent exact calculations but rather expectations based on historical claims’ trend (frequency and severity), payments’ pattern, medical inflation, members’ behaviour, seasonality and other factors. The Company has a large insurance portfolio resulting in stable claims development patterns which relatively reduces the risk of fluctuations in the estimated ultimate claims. The short-tailed nature of the business is associated with higher consistency of the reserve estimates. The Company continually review the adequacy of claims reserves by conducting back-testing analysis, assessing the sufficiency of data, monitoring claims backlogs and settlement patterns. In addition, the external actuary runs independent valuation models after due reconciliation with financial statements to validate reserve adequacy.ii)Concentration of insurance risk The insurance risk exposure related to policyholders is mainly concentrated in Saudi Arabia. However, through its underwriting strategy, the Company ensures that the portfolio is well diversified and not concentrated within few large clients. Its business is proportionally spread across all regions in the Saudi Arabia, and the Company targets both corporate and retail business. The insurance portfolio is not concentrated in a specific benefit level (diverse medical providers, different deductibles, annual limits and sub-limits)iii)Process used to decide on assumptionsThe pricing team follows the Company’s underwriting guidelines (approved by the Board of Directors) in setting premiums taking into consideration credible claims experiences for both new business and renewals or medical declarations. Assumptions used in determining claims reserves are based on the best estimate. Ultimate claims are estimated using historical claim trends adjusted for inflation, seasonality, membership growth and any other external or internal factors that may have impact on claim costs. Given the nature of the business, the Company may still be exposed to risk of insufficiency of claim reserves for which actual claim cost may turn out to be higher than the initial estimated ultimate claims. The estimation of IBNR is generally subject to a greater degree of uncertainty than the estimation of the outstanding claims which are received but not yet settled with the providers. For the case of outstanding claims, the Company uses payment information of settled batches with providers to estimate the expected settlement amounts of recently submitted batches, while it uses mainly pre-authorization data to estimate IBNR. The Company seeks to avoid inadequate reserve levels by adopting established processes in determining claim reserve and using updated information from both claims received and pre-authorization data.The premium liabilities have been determined as such that the total premium liability provisions (unearned premium reserve and premium deficiency reserve, if applicable and required as per the result of the liability adequacy test) would be sufficient to service the future expected claims and expenses likely to occur on the unexpired policies. The expected future liability is determined using the Company’s loss ratio adjusted for seasonality and portfolio mix for the remaining unearned period. The details of estimation of the outstanding claims and premium deficiency reserves are given under Notes 2(d)(i).iv)Sensitivity analysis The Company believes that the claim liabilities under insurance contracts outstanding at year-end are adequate. However, these amounts are not certain and actual payments may differ from the claims liabilities provided in the financial statements. The insurance claim liabilities are sensitive to the various assumptions. It has not been possible to quantify the sensitivity of specific variable such as legislative changes or uncertainty in the estimation process. An assumed 5% change in the claims’ ratio, net of reinsurance, would impact net underwriting income as follows:20212020SR’000SR’000Impact of change in claims ratio by 5%530,885 536,724	35.A
Disclosure of reinsurance/ retakaful risk [text block]	Reinsurance risk The Company has a reinsurance arrangement to reduce its exposure through transfer of insurance risk. The reinsurance agreement is an excess of loss treaty per person per claim on losses occurring basis. Such arrangement protects the Company from large claims with a reasonable ceded premium given the stable underwriting performance and the size of the insurance portfolio.The Reinsurers are selected based on the following criteria:- All reinsurers should meet SAMA’s minimum acceptable rating of BBB (S&P Rating). - The reinsurers’ panel and the agreement should be reviewed and approved by the Company’s Board of Directors.Reinsurance ceded business does not relieve the Company from its obligations to policyholders and as a result the Company remains liable for the portion of outstanding claims reinsured to the extent that the reinsurer fails to meet the obligations under the reinsurance agreements.	35.B
Disclosure of market risk [text block]	Market risk Market risk refers to the potential impact of various market dynamics on the fair value or the expected cash flows of financial instruments. The Company adopts asset allocation guidelines and diversification limits on asset classes, geographies, currencies and securities to ensure that market risk is contained and kept to minimal levels. The Board of Directors sets the overall risk appetite to a prudent level that does not impact the Company’s operating results. The management prepares monthly and quarterly reports, highlighting deployment activities and exposure limits to ensure that appropriate monitoring and compliance with the approved guidelines. Management performs continuous assessment of developments in relevant markets to ensure that market risk is monitored and mitigated at the asset class and securities levels. Market risk comprises three types: interest rate risk, price risk and currency risk. i)Interest rate risk Interest rate risk is the potential change in the fair value of financial instruments and expected cash flows as a result of changes in interest rates. Management constantly monitors developments in global and local interest rates and accordingly allocates the durations of its term deposits and sukuk investments. Investments in term deposits and sukuk instruments have various maturities in order to maximise investment returns while ensuring that liquidity requirements are continuously met. Details of maturities of interest-bearing securities as at 31 December are as follows:2021Less than 3 months3 months to 1 yearMore than 1 year to 3 yearsMore than 3 yearsTotalSR’000Term deposits 200,000 1,424,328 1,293,118 150,000 3,067,446 Investments in Sukuk - AFS 103,891 10,121 300,975 1,138,522 1,553,509 Investments in Sukuk - FVSI 26,000 -- 18,000 29,059 73,059Investments in Sukuk - HTM -- -- -- 331,250 331,250 329,8911,434,4491,612,0931,648,8315,025,2642020Less than 3 months3 months to 1 year1 year to 3 yearsMore than 3 yearsTotalSR’000Term deposits668,5551,011,500650,094393,0242,723,173Investments in Sukuk - AFS125,00088,089306,4721,188,7651,708,326Investments in Sukuk - FVSI --26,000--47,10473,104 Investments in Sukuk - HTM ------131,250131,250793,5551,125,589956,5661,760,1434,635,853ii)Price risk Price risk is the potential change in the fair value of financial instruments as a result of instrument-specific developments or systemic factors affecting the overall market in which the instrument is being traded.The total size of investments which are exposed to market price risk is SR 5,704 million (2020: SR 6,029 million). The Company manages this risk conducting thorough due diligence on each instrument prior to investing as well as maintaining exposure limits guidelines to minimise the potential impact of marking to market on the overall portfolio. The potential impact of a 10% increase or decrease in the market prices of investments on Company's profit would be as follows: Fair value changeEffect on Company’s profit SR’0002021 10% 32,5862020 10% 22,378The above sensitivity analysis is only on FVSI investments which directly impact the Company’s profit. iii)Currency risk Currency risk is the potential fluctuation of the value of a financial instrument due to changes in foreign exchange rates. All Company’s transactions are in Saudi Arabian Riyals and US Dollar. Given the peg of Saudi Arabian Riyals and US Dollars, foreign exchange risk is minimal.	35.C
Disclosure of credit risk [text block]	Credit risk Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company seeks to manage its credit risk with respect to customers by following the Company’s credit control policy and monitoring outstanding receivables on an on-going basis in order to reduce the Company’s exposure to bad debts. The management estimates specific impairment provisions on a case by case basis. In addition to specific provisions, the Company also makes an additional portfolio provision, estimated on a collective basis, based on the ageing profile of the premiums receivable. The Company seeks to limit its credit risk with respect to other counterparties by placing term deposits and investments with reputable financial institutions. The Company enters into reinsurance contracts with recognised, creditworthy third parties (rated A or above).The following table shows the maximum exposure to credit risk by class of financial asset:20212020SR’000SR’000Cash and cash equivalents960,758633,251Premiums receivable – net1,761,3001,320,043Reinsurers’ share of outstanding claims7,2071,475Reinsurers’ share of claims incurred but not reported7,8296,461Investments1,957,8181,912,680Other receivables85,885109,931Term deposits3,093,7202,796,547Statutory deposit120,000120,000Accrued income on statutory deposit14,88513,8068,009,4026,914,194The table below provides information regarding the credit risk exposure of the Company by classifying assets according to the Company’s credit rating of counterparties. Investment grade ratings refers to companies with sound credit standing of AAA to BBB- (as per S&P) and/or Aaa to Baa3 (as per Moody’s). Ratings below the mentioned threshold are considered sub-investment grade with a higher default risk. 2021Non-investment gradeInvestment gradeNot impairedImpairedTotalSR’000Cash and cash equivalents960,758----960,758Premiums receivable – net1,761,300----1,761,300Reinsurers’ share of outstanding claims7,207----7,207Reinsurers’ share of claims Incurred but not reported7,829----7,829Investments1,957,818----1,957,818Other receivables85,885----85,885Term deposits 3,093,720----3,093,720Statutory deposit120,000----120,000Accrued income on statutory deposit14,885----14,8858,009,402----8,009,4022020Non-investment gradeInvestment gradeNot impairedImpairedTotalSR’000Cash and cash equivalents633,251----633,251Premiums receivable – net1,320,043----1,320,043Reinsurers’ share of outstanding claims1,475----1,475Reinsurers’ share of claims Incurred but not reported6,461----6,461Investments1,912,680----1,912,680Other receivables109,931----109,931Term deposits 2,796,547----2,796,547Statutory deposit120,000----120,000Accrued income on statutory deposit13,806----13,8066,914,194----6,914,194	35.D
Disclosure of liquidity risk [text block]	Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its operational or financial obligations when they are due. Liquidity requirements are monitored on monthly basis and management ensures that sufficient liquid funds are available to meet any commitments as they arise.Unearned premiums have been excluded from the analysis as they are not contractual obligations. The table below summarises the maturity profile of the financial liabilities of the Company based on remaining expected undiscounted contractual obligations:2021Up toone yearMore thanone yearTotalSR’000Accrued and other liabilities604,774--604,774Lease liability--125,333125,333Insurance operations’ surplus payable190,060--190,060Reinsurers' balances payable25,397--25,397Outstanding claims601,168--601,168Claims incurred but not reported1,413,888--1,413,888Premium deficiency reserve74,602--74,602Claims handling reserve21,797--21,797Due to related parties33,723--33,723Accrued income payable to SAMA--14,88514,8852,965,409 140,218 3,105,627 2020Up toone yearMore thanone yearTotalSR’000Accrued and other liabilities540,450--540,450Lease liability--135,600135,600Insurance operations’ surplus payable200,391--200,391Reinsurers' balances payable4,873--4,873Outstanding claims446,519--446,519Claims incurred but not reported1,378,294--1,378,294Premium deficiency Reserve263,751--263,751Claims handling reserve20,755--20,755Due to related parties108,521--108,521Accrued income payable to SAMA--13,80613,8062,963,554149,4063,112,960 Liquidity profile All assets excluding investments, Fixtures, Furniture and Right-of-use assets, intangible assets, goodwill, statutory deposit and accrued income on statutory deposit, are expected to be recovered or settled before one year. Term deposits amounting to SR 2,124 million (31 December 2020: SR 1,680 million) mature within one year and the remaining balance have maturities greater than one year.None of the financial liabilities on the statement of financial position are based on discounted cash flows, with exception of end-of-service benefits and are all payable on a basis as set out above. There are no differences between contractual and expected maturity of the financial liabilities of the Company.	35. E - F
Disclosure of operational/ process risk [text block]	Operational risk is the risk of direct or indirect loss arising from a wide variety of causes associated with the processes, technology and infrastructure supporting the Company’s operations either internally within the Company or externally at the Company’s service providers, and from factors other than credit, market and liquidity risks such as those arising from regulatory requirements. Operational risks arise from all of the Company’s activities.The Company’s objective is to manage operational risk so as to balance limiting of financial losses and damage to its reputation with achieving its investment objective of generating returns for investors. The primary responsibility for the development and implementation of controls over operational risk rests with the Board of Directors. This responsibility encompasses the controls in the following areas:-Requirements for appropriate segregation of duties between various functions, roles and responsibilities;-Requirements for the reconciliation and monitoring of transactions;-Compliance with regulatory and other legal requirements;-Documentation of controls and procedures;-Requirements for the periodic assessment of operational risks, and the adequacy of controls and procedures to address those risks;-Ethical and business standards; and-Risk mitigation policies and procedures.	35.Z
Disclosure of fair value of financial assets and liabilities [text block]	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction takes place either:-in the accessible principal market for the asset or liability, or-in the absence of a principal market, in the most advantageous accessible market for the asset or liability.a)Determination of fair value and fair value hierarchyThe Company uses the following hierarchy for determining and disclosing the fair value of financial instruments:Level 1: quoted prices in active markets for the same or identical instrument that an entity can access at the measurement date;Level 2: quoted prices in active markets for similar assets and liabilities or other valuation techniques for which all significant inputs are based on observable market data; andLevel 3: valuation techniques for which any significant input is not based on observable market data.b)Carrying amounts and fair valueThe following table shows the carrying amount and fair value of financial assets, including their levels in the fair value hierarchy for financial instruments measured at fair value. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation to fair value. There were no transfers in between levels during the years ended December 31, 2021 and 2020.Fair valueLevel 1Level 2Level 3TotalCarrying valueSR’0002021Financial assets measured at fair value- Investments held as FVSI-- 3,257,935 -- 3,257,935 3,257,935- Available-for-sale investments 1,421,562 670,903 22,123 2,114,588 2,114,588 1,421,562 3,928,838 22,123 5,372,5235,372,523 Fair valueLevel 1Level 2Level 3TotalCarrying valueSR’0002020Financial assets measured at fair value- Investments held as FVSI-- 3,694,761 -- 3,694,761 3,694,761 - Available for sale investments 1,404,736 793,074 5,625 2,203,435 2,203,435 1,404,736 4,487,835 5,625 5,898,196 5,898,196 c)Measurement of fair valueValuation technique and significant unobservable inputsThe following table shows the valuation techniques used in measuring Level 2 fair value at 31 December 2021 and 31 December 2020, as well as the significant unobservable inputs used. TypeValuation techniqueSignificant unobservable inputsInter-relationship between significant unobservable inputs and fair value measurementFloating rate sukuks and mutual funds Valuations are based on quotations as received by the custodians at the end of each period and on published net asset value (NAV) closing prices.Not applicableNot applicable	22
Disclosure of comparative figures [text block]	Certain comparative figures have been restated to conform with the current year’s presentation to these financial statements. These restatement have no impact on the net income for the year ended 31 December 2021 and retained earnings as at 31 December 2021.As at 31 December 2020, an amount of SR 125.6 million has been reclassified from ‘Fixtures, Furniture andRight-of-use assets – net’ to ‘Right-of-use assets – net’. Similarly as at 31 December 2020, an amount of SR 135.6 million has been reclassified from ‘Accrued and other liabilities’ to ‘Lease liability’. In addition, an amount of SR 73.4 million has been reclassified from ‘Prepaid expenses and other assets’ to ‘Term deposits’.	37
Disclosure of board of director's approval of the financial statements [text block]	The financial statements have been approved by the Board of Directors, on 22 Rajab 1443H corresponding to 23 February 2022.	40
Disclosure of other notes relevant to understanding of financial statements [text block]	4.GOODWILLOn 31 December 2008, the Company entered into an agreement with Bupa Middle East Limited E.C. (the “Seller”), a related party, pursuant to which it acquired the Seller’s insurance operations in the Kingdom of Saudi Arabia, effective from 1 January 2009. The acquisition transaction was approved by SAMA and resulted in goodwill of SR 98 million. The entire amount was paid in the previous years, to the Seller, after obtaining the required regulatory approvals.The Company’s management annually carry out impairment test in respect of the above-mentioned goodwill. Management conducted the impairment exercise for the year ended 31 December 2021. The recoverable amount of operations has been determined based on value in use. The two key assumptions used in the test are the discount rate and estimated future cash flows from the business as follows:An average discount rate of 12% was used to discount future cash flows. EBTIDA growth rate of 3% was used for the first three years. Thereafter, a growth rate of 3% was used in the terminal value calculation.A change in discount rate by +/- 300 basis point with other variables held constant would not result in impairment of goodwill.A change in growth rate by +/- 150 basis point with other variables held constant would not result in impairment of goodwill.11. INTANGIBLE ASSETS SoftwareCapital work in progressTotal2021 SR’000Cost:At 1 January 2021139,53818,484158,022Additions during the year 10019,66519,765Transfers during the year12,902(12,902)--At 31 December 2021152,54025,247177,787Accumulated amortization:At 1 January 2021(96,064)--(96,064)Charge for the year(14,446)--(14,446)At 31 December 2021(110,510)--(110,510)Net book value:At 31 December 202142,03025,24767,277 SoftwareCapital work in progressTotal2020 SR’000Cost:At 1 January 2020 128,3168,262136,578Additions during the year 1,45319,99121,444Transfers during the year9,769(9,769)--At 31 December 2020 139,53818,484158,022Accumulated amortisation:At 1 January 2020(80,333)--(80,333)Charge for the year(15,731)--(15,731)At 31 December 2020(96,064)--(96,064)Net book value:At 31 December 202043,47418,48461,95816. FIDUCIARY ASSETS During the year ended 31 December 2018, after obtaining SAMA’s approval, the Company entered into a Third Party Administration agreement (TPA) with a customer under which the Company facilitates healthcare services to the employees of the customer with specific terms and conditions. The agreement is effective from 1 March 2018. The services are remunerated against administration fees. In order to fulfil the commitment relating to this agreement, the Company has received funds in advance from the customer to settle anticipated claims from medical service providers. As the Company acts as an agent, the relevant bank balance and outstanding claims at the reporting date, are excluded from the statement of financial position. The assets and liabilities held in fiduciary capacity amounted to SR 260 million as of 31 December 2021 (2020: SR 317.1 million).36.SUPPLEMENTARY INFORMATIONStatement of Financial Position 20212020Insurance operationsShareholders’ operationsTotalInsurance operationsShareholders’ operationsTotalSR’000SR’000SR’000SR’000SR’000SR’000ASSETSCash and cash equivalents930,69130,067960,758195,232438,019633,251Premiums receivables – net1,761,300--1,761,3001,320,043--1,320,043Reinsurers’ share of unearned premiums27,935--27,93520,108--20,108Reinsurers’ share of outstanding claims7,207--7,2071,475--1,475Reinsurers’ share of claims Incurred but not reported7,829--7,8296,461--6,461Deferred policy acquisition costs201,042--201,04268,214--68,214Investments2,599,4293,104,3445,703,7733,568,1812,461,2656,029,446Prepaid expenses and other assets99,99813,256113,25471,16713,91985,086Term deposits2,007,9221,085,7983,093,7201,645,2921,151,2552,796,547Fixtures, Furniture – net--69,77169,771--78,393 78,393 Right-of-use assets – net--112,616112,616--125,626125,626Intangible assets – net--67,27767,277--61,95861,958Deferred tax asset--39,73539,735--37,94137,941Goodwill--98,00098,000--98,00098,000Statutory deposit--120,000120,000--120,000120,000Accrued income on statutory deposit--14,88514,885--13,80613,806TOTAL ASSETS7,643,3534,755,74912,399,1026,896,1734,600,18211,496,355LIABILITIESAccrued and other liabilities597,9116,863604,774534,2016,249540,450Lease liability--125,333125,333--135,600135,600Insurance operations’ surplus payable190,060--190,060200,391--200,391Reinsurers’ balances payable25,397--25,3974,873--4,873Unearned premiums4,709,555--4,709,5554,023,331--4,023,331Outstanding claims601,168--601,168446,519--446,519Claims incurred but not reported1,413,888--1,413,8881,378,294--1,378,294Premium deficiency reserve74,602--74,602263,751--263,751Claims handling reserve21,797--21,79720,755--20,755Due to related parties--33,72333,723--108,521108,521Provision for end-of-service benefits (EOSB)--152,286152,286--140,012140,012Provision for zakat and income tax--236,610236,610--317,199317,199Accrued income payable to SAMA--14,88514,885--13,80613,806TOTAL LIABILITIES7,634,378569,7008,204,0786,872,115721,3877,593,502EQUITYShare capital--1,200,0001,200,000--1,200,0001,200,000Statutory reserve--992,210992,210--867,096867,096Share based payments reserve--43,50043,500--32,80032,800Shares held under employees share scheme--(53,356)(53,356)--(48,779)(48,779)Retained earnings --1,790,7001,790,700--1,684,0031,684,003Re-measurement reserve of end-of-service benefits--(23,638)(23,638)--(31,173)(31,173)Investments fair value reserve8,975236,633245,60824,058174,848198,906TOTAL EQUITY8,9754,186,0494,195,02424,0583,878,7953,902,853TOTAL LIABILITIES AND EQUITY7,643,3534,755,74912,399,1026,896,1734,600,18211,496,355Statement of Income20212020Insurance operationsShare-holders’ operationsTotalInsurance operationsShare-holders’ operationsTotalSR’000SR’000SR’000SR’000SR’000SR’000REVENUESGross premiums written11,382,194--11,382,19410,447,353--10,447,353Reinsurance premiums ceded – Local (5,345)--(5,345)(5,953)--(5,953)Reinsurance premiums ceded – International (80,737)--(80,737)(59,289)--(59,289)Net premiums written11,296,112--11,296,11210,382,111--10,382,111Changes in unearned premiums – net(678,397)--(678,397)352,371--352,371Net premiums earned10,617,715--10,617,71510,734,482--10,734,482UNDERWRITING COSTS & EXPENSESGross claims paid (9,073,926)--(9,073,926)(8,262,050)--(8,262,050)Reinsurers’ share of claims paid22,393--22,39320,987--20,987Net claims paid (9,051,533)--(9,051,533)(8,241,063)--(8,241,063)Changes in outstanding claims(154,649)--(154,649)5,269--5,269Changes in claims incurred but not reported(35,594)--(35,594)(220,866)--(220,866)Changes in Premium deficiency Reserve189,149--189,149(263,751)--(263,751)Changes in claims handling reserves (1,042)--(1,042)(2,263)--(2,263)Reinsurance share of changes in outstanding claims 5,732--5,732257--257Reinsurance share of changes in claims incurred but not reported1,368--1,3682,489--2,489Net claims incurred(9,046,569)--(9,046,569)(8,719,928)--(8,719,928)Policy acquisition costs(343,427)--(343,427)(630,734)--(630,734)TOTAL UNDERWRITING COSTS & EXPENSES(9,389,996)--(9,389,996)(9,350,662)--(9,350,662)NET UNDERWRITING INCOME1,227,719--1,227,7191,383,820--1,383,820OTHER OPERATING (EXPENSES)/ INCOMEAllowance for doubtful receivables(22,458)--(22,458)(28,770)--(28,770)General and administrative expenses(586,004)(12,590)(598,594)(565,199)(20,350)(585,549)Selling and marketing expenses(115,646)--(115,646)(106,467)--(106,467)Investment income – net84,843175,594260,437121,78891,507213,295 Other income – net(4,985)42,57537,590(3,762)31,24327,481Total Other Operating (expenses)/ income(644,250)205,579(438,671)(582,410)102,400(480,010)Income before surplus, zakat & income tax583,469205,579789,048801,410102,400903,810Transfer of surplus to shareholders(525,122)525,122--(721,269)721,269--Income attributed to the shareholders before zakat and income tax58,347730,701789,04880,141823,669903,810Zakat charge --(41,136)(41,136) --(64,297)(64,297)Income tax charge--(63,995)(63,995)--(63,244)(63,244)NET INCOME ATTRIBUTED TO THE SHAREHOLDERS AFTER ZAKAT AND INCOME TAX58,347625,570683,91780,141696,128776,269Weighted average number of ordinary outstanding shares (in thousands)119,558119,421Basic and diluted earnings per share (Expressed in SR per Share)5.235.83Statement of Comprehensive Income20212020Insurance operationsShare-holders’ operationsTotalInsurance operationsShare-holders’ operationsTotalSR’000SR’000SR’000SR’000SR’000SR’000Net income attributed to the shareholders after zakat and income tax58,347625,570683,91780,141696,128776,269Other comprehensive incomeItems that will not be reclassified to statements of income in subsequent yearsRe-measurement losses on employees’ EOSB--7,5357,535--(20,700)(20,700)Items that are or may be reclassified to statement of income in subsequent yearsNet changes in fair value of available-for-sale investments(15,083)61,78546,70211,554156,813168,367TOTAL COMPREHENSIVE INCOME43,264694,890738,15491,695832,241923,936Reconciliation:Less: Net income attributable to insurance operations transferred to surplus payable(58,347)(80,141)TOTAL COMPREHENSIVE INCOME FOR THE YEAR679,807843,795Statement of Cash flows20212020Insurance operationsShare-holders’ operationsTotalInsurance operationsShare-holders’ operationsTotalSR’000SR’000SR’000SR’000SR’000SR’000CASH FLOWS FROM OPERATING ACTIVITIESNet income attributed to the shareholders before zakat and income tax--730,701730,701--823,669823,669Adjustments for non-cash items:Net income attributed to the insurance operations58,347--58,34780,141--80,141Depreciation of Fixtures, Furniture 15,216--15,21615,266--15,266Amortisation of Right-of-use assets15,939--15,93916,241--16,241Amortisation of intangible assets14,446--14,44615,731--15,731Loss on disposal of Fixtures and Furniture --2,5212,521------Provision for LTIP--20,38620,386--16,03416,034Allowance of doubtful receivables 22,458--22,45828,770--28,770Unrealised gains on investments held as FVSI --(2,643)(2,643)(1,058)182(876)Commission Income on Term Deposits(31,182)(27,175)(58,357)(79,901)(40,277)(120,178)Provision for end-of-service benefits--27,49527,495--27,29427,294Finance cost--5,8345,834--5,2445,244Changes in operating assets and liabilities:Premiums receivable (463,715) --(463,715) 340,564--340,564Reinsurers’ share of unearned premiums(7,827) --(7,827) 517--517Reinsurers’ share of outstanding claims(5,732)--(5,732)(257)--(257)Reinsurers’ share of claims incurred but not reported(1,368)-- (1,368)(2,489)--(2,489)Deferred policy acquisition costs (132,828) -- (132,828)65,808--65,808Prepaid expenses and other assets(28,831)663(28,168) 92,1679,056101,223Accrued and other liabilities63,71061464,324181,403689 182,092Reinsurers’ balances payable20,524--20,524(49,540)--(49,540)Unearned premiums686,224--686,224(352,888)--(352,888)Outstanding claims154,649--154,649(5,269)--(5,269)Claims incurred but not reported35,594--35,594220,866--220,866Premium deficiency reserve(189,149)--(189,149)263,751--263,751Claims handling reserve1,042--1,0422,263--2,263Due to related parties--(60,557)(60,557)--27,80027,800Due to shareholders’ operations(48,133)48,133--(47,239)47,239--179,384745,972925,356784,847916,9301,701,777End-of-service benefits paid--(7,686)(7,686)--(4,323)(4,323)Surplus paid to policyholders(68,678)--(68,678)(48,204)--(48,204)Zakat and income tax paid --(187,514)(187,514)--(92,776)(92,776)Net cash generated from operating activities110,706 550,772661,478736,643819,8311,556,474Placement in term deposits(1,839,000)(374,328)(2,213,328) (488,850) (300,000) (788,850)Proceeds from maturity of term deposits1,507,552466,9601,974,5122,330,514 936,277 3,266,791Additions to investments(8,132,760)(7,033,358) (15,166,118)(9,765,721)(3,983,139)(13,748,860)Disposals of investments9,088,9616,452,175 15,541,136 6,935,704 2,793,785 9,729,489 Additions to Fixtures, Furniture--(9,115)(9,115)--(11,840)(11,840)Disposal of Fixtures, Furniture------------Intangible assets acquired--(19,765)(19,765)--(21,444)(21,444)Net cash used in investing activities624,753(517,431)107,322(988,353)(586,361)(1,574,714)CASH FLOWS FROM FINANCING ACTIVITIESDividends paid --(408,000)(408,000)------Purchase of shares under LTIP--(14,263)(14,263)-- ---- Lease liability paid --(19,030)(19,030)--(14,218)(14,218) Net cash used in financing activities--(441,293)(441,293)--(14,218)(14,218) Net change in cash and cash equivalents735,459(407,952) 327,507 (251,710) 219,252 (32,458)Cash and cash equivalents at beginning of the year195,232438,019633,251 446,942 218,767 665,709 Cash and cash equivalents at end of the year 930,69130,067 960,758195,232438,019633,25138.IMPACT OF COVID-19 COMPENSATION FOR GOVERNMENT PROVIDERS As many world economies grapple with the coronavirus (“COVID-19”) uncertainties, Bupa Arabia continues to monitor the situation closely and refresh its business continuity and risk management plans to ensure sustainability of its current service levels and operational activities under different scenarios while preserving the safety and health of its employees. COVID-19 is having a profound impact on many facets of the health insurance sector, including medical claim patterns as explained below. Given the many uncertainties surrounding the duration and severity of the pandemic, management continues reassessing and updating its estimates and judgments on a regular basis. Actual outcomes may differ from those projected. The liquidity and solvency positions of the Company remain strong as at the date of issuing these interim condensed financial statements.After Saudi Arabia started easing COVID-19 lockdown and curfew measures towards the end of second quarter of 2020 for which a substantial drop in claims was observed, the demand for healthcare services gradually recovered during the second half of 2020 and throughout 2021. The claims levels in the second half of 2021 exceeded those of pre-COVID periods. The Company expects this pattern to persist over the next months; hence, the company still holds a PDR balance of SR 74.6 m to ensure it holds adequate reserves to cover for the surge in claims. This PDR calculation follows SAMA Circular 173 dated 16/01/2019, which requires insurance companies to hold a Premium Deficiency Reserve (“PDR”) in case the relevant Unearned Premium Reserve (“UPR”) is insufficient to cover related projected claims and expenses.Impact of Government Providers The Council of Cooperative Health Insurance (“CCHI”) issued Circular 895, dated 17/12/2020, regarding the enforcement of Article 11 of the Cooperative Health Insurance Law, requesting medical insurance companies, effective 1/1/2021, to include all accredited government healthcare providers in their medical network while complying with the approved financial compensation structure. The circular is expected to have a material impact on future medical claims considering the mandated prices and protocols regulating the relationship between government health facilities and insurance companies. Given the many uncertainties surrounding the actual rollout and application of Circular 895, management continues monitoring the situation closely, while reassessing and updating its estimates and judgments on a regular basis. 39.DIVIDENDS DECLAREDOn 25 April 2021, the Company’s Board of Directors proposed to pay dividends, for the year ended 31 December 2020, of SR 3.4 per share, totalling SR 408 million, to its shareholders. The dividends were approved by the shareholders in the Extraordinary General Assembly meeting, held on 24 June 2021, with payment executed in July 2021.	4 - 11 - 16 - 36 - 38 - 39
Disclosure of fees and commission income [text block]	During 2010, the Company entered into an agreement with a related party (a Group Company) for obtaining a license to use the trademark (the word Bupa with or without logo) of the related party. As per the terms of the agreement, the trademark fee is payable at different rates linked to the results of the Company, subject to a maximum of 5% of the Company’s profits in any financial year. Accordingly, a sum of SR 26.6 million (2020: SR 26.9 million) payable to a related party has been accrued for during the year (see notes 24 and 32).	19

[100010] Filing information	[200100] Independent auditors report	[300100] Statement of financial position, order of liquidity
[300200] Statement of insurance/ takaful operations, nature of expense	[300300] Statement of shareholders operations, nature of expense	[300400] Statement of other comprehensive income, before tax, insurance operations
[300500] Statement of other comprehensive income, before tax, shareholders operations	[300600] Statement of cash flows, indirect method, insurance operations	[300700] Statement of cash flows, indirect method, shareholders operations
[300800] Statement of changes in equity	[400100] Notes forming part of accounts